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ABSTRACT OF THE DISSERTATION
The Nrl Photoreceptor Cell Fate Switch: Endogenous Regulation and Therapeutic
Applications
by
Cynthia Lee Montana
Doctor of Philosophy in Biology & Biomedical Sciences
Molecular Cell Biology
Washington University in St. Louis, 2014
Professor Joseph Corbo, Chairperson

The transcription factor neural retina leucine zipper (Nrl) is a critical determinant of rod
photoreceptor fate and a key regulator of rod differentiation. Nrl-/- rod precursors fail to
turn on rod genes and instead differentiate as cones. Furthermore, NRL mutations in
humans cause retinitis pigmentosa, a potentially debilitating disease.

Despite the

developmental and clinical significance of this gene, however, little is known about the
transcriptional regulation of Nrl itself. In this study, we sought to define the cis- and
trans-acting factors responsible for initiation and maintenance of Nrl transcription in the
mouse retina. Utilizing a quantitative mouse retinal explant electroporation assay, we
discovered a phylogenetically conserved, 30-base pair region immediately upstream of
the transcription start site that is required for Nrl promoter activity. This region contains
critical binding sites for the retinal transcription factors Crx, Otx2, and RORβ, and
experiments demonstrate binding of these factors both in vitro and in vivo. We propose a

x

model in which Nrl expression is primarily initiated by Otx2 and RORβ and later
maintained at high levels by Crx and RORβ.
In addition to elucidating the developmental regulation of Nrl, we sought to
determine whether manipulation of this photoreceptor cell fate switch might be
applicable to the treatment of heritable blindness. Retinitis pigmentosa is one of the most
common degenerative diseases of the eye and is associated with early rod photoreceptor
death followed by secondary cone degeneration. We hypothesized that converting adult
rods into cones would make the cells resistant to the effects of mutations in rod-specific
genes, thereby preventing secondary cone loss.

To test this idea, we engineered a

tamoxifen-inducible allele of Nrl to acutely inactivate the gene in adult rods. This
manipulation resulted in reprogramming of rods into cells with cone-like molecular,
histologic and functional properties. Moreover, reprogramming of adult rods achieved
cellular and functional rescue of retinal degeneration in a mouse model of retinitis
pigmentosa. These findings suggest that elimination of Nrl in adult rods may represent a
novel therapy for retinal degeneration.
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CHAPTER 1

Introduction to retinal development, neural retina
leucine zipper (Nrl), and somatic cell
reprogramming

1

1.1

The retinal progenitor cell and fate specification

The sense of sight is an ancient and important adaptation for many animal species. The
molecular pathways for light perception have evolved steadily over the past 600 million
years, from the light-sensitive pigments of cnidarians (Plachetzki et al., 2007) to the
complex neural interface of vertebrates. Scientists have turned to many model systems to
study the visual system, including the rodent, chicken, zebrafish, frog, salamander, and
even jumping spider. Visual perception in these animals begins with the retina, a lightsensitive neural tissue at the back of the eye. The vertebrate retina contains six neuronal
and one glial cell type organized into distinct layers. Rod and cone photoreceptors,
residing in the outer nuclear layer (ONL), detect photons and convert light input into
chemical output. Horizontal cells, bipolar cells, and amacrine cells, residing in the inner
nuclear layer (INL), integrate the photoreceptor output and transmit the signal to retinal
ganglion cells in the ganglion cell layer (GCL). Retinal ganglion cells then relay the
partially processed visual information to the brain via the optic nerve.

The multi-potent retinal progenitor cell
The beautifully laminar structure of the vertebrate retina, as well as characteristic
morphological features of the various retinal cell types (Cajal, 1893), have facilitated
rigorous cell birthdating studies that form the groundwork for the study of retinal
development (Carter-Dawson and LaVail, 1979b; Young, 1985). Classic H3-thymidine
labeling experiments have established the order of retinal cell differentiation in the
mouse:

most retinal ganglion cells, horizontal cells, amacrine cells, and cone
2

photoreceptors are born prenatally, while bipolar cells and Müller glia are born
postnatally. The window of rod photoreceptor birth extends from embryonic day 12
(E12) through postnatal day 11 (P11), with the peak of differentiation occurring around
P0 (Young, 1985). For both rods and cones, cell birth in the central retina precedes that
in the peripheral retina by two to three days (Carter-Dawson and LaVail, 1979b).
The progressive generation of retinal cell types gives rise to a fundamental
question: does a common, multi-potent progenitor cell produce all cell types, or is the
fate of a given progenitor restricted to a subset of cell type(s)? Several elegant studies
indicate that retinal progenitor cells are indeed competent to produce all retinal cell types.
In experiments conducted in the chicken, rat, mouse, and frog, single embryonic
progenitor cells were labeled by either replication-incompetent retroviral vectors (Fekete
et al., 1994; Turner and Cepko, 1987; Turner et al., 1990) or cellular injection (Holt et al.,
1988; Wetts and Fraser, 1988). Following the completion of retinal development, the
labeled progenitors were found to have given rise to various combinations of all retinal
cell types.

The competence model of retinal cell fate specification
Given that cycling progenitor cells are multi-potent, what factors then specify the fate of
post-mitotic daughter cells?

Evidence from many experiments in different model

systems supports the ‘competence model’ of retinal cell fate specification that
incorporates both intrinsic and extrinsic cues (reviewed in Cepko et al., 1996; Livesey
and Cepko, 2001). In this model, cycling progenitors pass through temporal stages
during which they are able, or competent, to produce only a subset of retinal cell types.
3

These competence stages are likely defined by intrinsic variables such as the expression
of specific transcription factors.

The type of cell produced during a particular

competence stage, on the other hand, is likely influenced by extrinsic factors such as
protein ligands and small molecules.

This model was established in large part by

heterochronic experiments, where labeled embryonic cells (E15 or E16) were
transplanted into cultures of postnatal cells (P0 or P1) (Belliveau and Cepko, 1999;
Watanabe and Raff, 1990). The postnatal environment was able to increase the number
of rods eventually produced from the embryonic cells, but not the number of other
postnatally born cell types such as bipolar cells and Müller glia.

Conversely, late

progenitor cells could not be induced efficiently in culture to adopt the fate of early-born
retinal ganglion cells (Austin et al., 1995).
Retinal culture systems have also been used to study the effects of specific
extrinsic factors on differentiation. Application of the cytokine CNTF to explanted rat
retinas, for example, causes rod photoreceptor precursors to instead differentiate as
bipolar cells (Ezzeddine et al., 1997). Alternatively, a number of soluble molecules have
been shown to promote rod photoreceptor differentiation, including taurine (Altshuler et
al., 1993; Young and Cepko, 2004), retinoic acid (Hyatt et al., 1996; Kelley et al., 1994;
Kelley et al., 1999; Osakada et al., 2008), and sonic hedgehog protein (Levine et al.,
1997; Stenkamp et al., 2000). Thus, the integration of intrinsic and environmental inputs
specifies the fate of post-mitotic retinal precursor cells.

4

1.2

bHLH

and

homeodomain

transcription

factors

in

photoreceptor

differentiation

Advances in transgenesis have greatly increased our understanding of specific signaling
pathways and transcription factors involved in retinal development. The roles of Notch
signaling (Perron and Harris, 2000), bHLH activators and repressors (Cepko, 1999;
Hatakeyama and Kageyama, 2004; Yan et al., 2005), and homeodomain transcription
factors (Hennig et al., 2008; Swaroop et al., 2010) have been particularly well studied. In
general, Notch signaling activates the repressor bHLH factors Hes1 and Hes2, which
maintain the progenitor state by suppressing the transcription of proneural bHLH factors.
Upon cessation of Notch signaling, proneural bHLH transcription factors such as Math5,
NeuroD, and Mash1 promote exit from the cell cycle and terminal differentiation (Jadhav
et al., 2006b; Riesenberg et al., 2009; Yaron et al., 2006).
The importance of Notch signaling in murine retinal development has been
confirmed by both loss- and gain-of-function experiments. Early deletion of Notch1 in
the mouse retina causes a large proportion of progenitor cells to differentiate prematurely
as cones, whereas later deletion results in overproduction of rods (Jadhav et al., 2006b).
Conversely, constitutive activation of the Notch pathway maintains the progenitor
population and eventually promotes glial and stem cell-like phenotypes in the adult retina
(Jadhav et al., 2006a). These results are in agreement with the competence model of
retinal differentiation (Cepko et al., 1996) and suggest an important role for downstream
bHLH factors in specifying retinal cell fate.

5

The interactions between proneural bHLH factors and other transcription factors
in the developing retina are complex, although a simplified model has been proposed
(Hatakeyama and Kageyama, 2004). In this model, homeodomain transcription factors
specify the retinal cell layer for a given precursor, and bHLH factors specify the neuronal
fate within the layer. Bipolar cells, for example, are directed to develop in the INL by the
homeodomain factor Chx10 (Burmeister et al., 1996; Hatakeyama et al., 2001), but
bipolar cell fate in particular is determined by the bHLH factors Mash1 and Math3
(Hatakeyama et al., 2001). The remainder of this discussion will concentrate on the role
of transcription factors specifically in photoreceptor differentiation (Fig. 1.1)

bHLH factors and photoreceptor specification
NeuroD is the best-studied bHLH factor implicated in photoreceptor differentiation, but
its precise actions during development are somewhat species-specific. In the chicken,
NeuroD appears to direct photoreceptor fate: suppression of NeuroD causes loss of
photoreceptor development (Yan and Wang, 2004), while overexpression in the retinal
neuroepithelium results in excess photoreceptors (Yan and Wang, 1998). The role of
NeuroD in the mouse retina is somewhat more complicated. NeuroD1 appears to specify
amacrine fate at the expense of bipolar cells (Morrow et al., 1999) but is also important
for long-term photoreceptor survival (Morrow et al., 1999; Pennesi et al., 2003). Other
NeuroD family members play yet other roles in retinal development (Cherry et al., 2011).
There is limited evidence for the direction of photoreceptor fate by additional
bHLH proteins such as Mash1 (Ahmad, 1995), Ngn1 (Yan et al., 2010), Ngn2 (Yan et al.,
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2001), and Math5 (Brown et al., 1998; Le et al., 2006), but further studies will be
required to elucidate the precise roles of these factors in photoreceptor differentiation.

Orthodenticle homeobox 2 (Otx2)
Notch-Hes signaling is thought to directly regulate the expression of Otx2 (Muranishi et
al., 2011), a bicoid class homeobox transcription factor required for the development of
the forebrain (Acampora et al., 1995; Ang et al., 1996; Matsuo et al., 1995). During
embryogenesis, Otx2 expression is widespread in the epiblast but eventually becomes
restricted to the forebrain and midbrain (Simeone et al., 1993). In the developing retina,
Otx2 expression is dynamic: at embryonic timepoints (E12.5-E17.5) it is expressed
strongly in the retinal pigment epithelium (RPE) and outer neuroblastic layer, which
eventually gives rise to the photoreceptors in the ONL. Postnatally, however, Otx2 is
downregulated in the ONL and upregulated in bipolar cells of the INL (Fossat et al.,
2007; Nishida et al., 2003).
Functionally, expression of Otx2 in the final cell cycle of retinal progenitor cells
is thought to signal commitment to the photoreceptor cell fate (Muranishi et al., 2011).
Otx2 is necessary for photoreceptor development: photoreceptor precursors in the Otx2
null retina instead develop as amacrine-like neurons (Nishida et al., 2003). Otx2 is also a
regulator of photoreceptor genes during early development, including the transcription
factor Crx (Nishida et al., 2003) and other genes such as Rho, Pde6b, and Sag (Koike et
al., 2007).

7

Cone-rod homeobox (Crx)
Crx is another homeobox transcription factor that acts immediately downstream of Otx2
to regulate the differentiation of both rod and cone photoreceptors (Chen et al., 1997;
Freund et al., 1997; Furukawa et al., 1997). Photoreceptors develop in the Crx null
retina, but they fail to adequately express a large cohort of rod- and cone-specific genes,
lack outer segments and light responsiveness, and eventually degenerate (Furukawa et al.,
1999). Traditional ChIP (Hennig et al., 2008; Peng and Chen, 2005) and ChIP-seq
studies (Corbo et al., 2010) suggest that Crx is a master regulator of nearly all
photoreceptor genes, binding directly to promoter and enhancer regions to activate
transcription.

In the developing retina, Crx is thought to regulate many genes

coordinately with Otx2 (Koike et al., 2007), as the two transcription factors have nearly
identical DNA binding domains (Chen et al., 1997; Furukawa et al., 1997) and DNA
binding preferences (Chatelain et al., 2006; Lee et al., 2010).
Unsurprisingly, mutations in human CRX result in a variety of retinal disease,
including Leber congenital amaurosis, cone-rod degeneration, and retinitis pigmentosa
(Freund et al., 1997; Rivolta et al., 2001). Many disease alleles are dominant, and the
pathogenic mechanism of various mutations is the subject of ongoing research.

1.3

Nrl and the specification of rod photoreceptor fate

The final stage of photoreceptor differentiation is commitment to either the rod or cone
lineage. A single transcription factor, Nrl, has been identified in the mouse as a ‘cell fate
switch’ between the rod and cone phenotypes: photoreceptor precursors that turn on Nrl
8

become rods, and those that do not become cones. The nature of this switch was
elucidated by the Nrl knockout mouse, which exhibits en masse conversion of all rod
photoreceptor precursors into blue cones (Akimoto et al., 2006; Mears et al., 2001).
These reprogrammed cones are fully functional and cause a phenotype similar to human
enhanced S-cone syndrome, with increased sensitivity to blue light (Daniele et al., 2005;
Haider et al., 2000). The all-cone, Nrl mutant retina experiences an early period of
photoreceptor cell death and inflammation, but degeneration ceases by 4 months and the
ONL is largely intact out to 10 months of age (Roger et al., 2012).
Nrl is not only necessary but also sufficient for rod photoreceptor specification.
Ectopic Nrl expression in all photoreceptors of wild-type and Nrl-/- mice, driven by the
Crx promoter, results in functional all-rod retinas (Oh et al., 2007).

The temporal

window for transformation of cone precursors into rods is limited, however, as ectopic
Nrl expression driven by the later-acting S-opsin promoter results in hybrid
photoreceptors expressing both rod and cone genes (Oh et al., 2007).

Regulation of Nrl expression
Nrl transcripts are first detectable in the developing retina at E12 (Akimoto et al., 2006),
coincident with the beginning of the rod photoreceptor birth period (Carter-Dawson and
LaVail, 1979b; Young, 1985). Nrl expression localizes to the outer neuroblastic layer of
the developing retina (Akimoto et al., 2006; Montana et al., 2011), and BrdU studies in
the pNrl-GFP transgenic mouse suggest that Nrl is turned on in a subset of photoreceptor
precursors shortly after the terminal mitosis (Akimoto et al., 2006). In adult mice the Nrl
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transcript localizes to the ONL (Hsiau et al., 2007), and antibody staining indicates that
the protein is restricted to the nuclei of rods but not cones (Swain et al., 2001).
While the rod-specific Nrl expression pattern has been well characterized, the
transcriptional mechanisms underlying this pattern were, up to now, largely unknown.
The core Nrl promoter has been identified as either a 3.2-kb (Matsuda and Cepko, 2004)
or 2.5-kb (Akimoto et al., 2006) region immediately upstream of the first exon. One
study of this region identified discrete binding sites for retinoic acid receptors (Khanna et
al., 2006), possibly explaining why retinoic acid is a strong inducer of rod differentiation
(Hyatt et al., 1996; Kelley et al., 1994; Kelley et al., 1999; Osakada et al., 2008). Other
transcription factors such as Crx (Corbo et al., 2010; Hsiau et al., 2007) and RORβ (Jia et
al., 2009) have been hypothesized to regulate Nrl, although prior to this work there has
been little evidence for direct transcriptional regulation. The first aim of this thesis
project, therefore, was to identify the discrete DNA binding sites and transcription
factors that regulate Nrl expression in the mouse retina.
Our work and other similar, recently published research (Kautzmann et al., 2011)
have elucidated factors contributing to Nrl regulation in rod photoreceptors, including
Crx, RORβ, and Otx2. However, one fundamental questions remains: what factors
determine whether or not a photoreceptor precursor will turn on Nrl initially? Many
binary cell fate decisions, similar to the rod versus cone decision, have been described in
the literature (Arinobu et al., 2007; Niwa et al., 2005; Schaffer et al., 2010), and they
often involve two antagonistic transcription factors that eventually promote one fate over
the other (reviewed in Zhou and Huang, 2011; Graf and Enver, 2009). It is possible,
therefore, that photoreceptor precursors may co-express Nrl and a second reciprocal
10

transcription factor that promotes cone cell fate. A cone-promoting factor has in fact
been identified in the zebrafish: loss of Tbx2b causes the ‘lots-of-rods’ phenotype where
there is a one-for-one transformation of UV-cone precursors into rods (Alvarez-Delfin et
al., 2009). Our unpublished studies of Tbx2 deletion in the mouse retina, however,
suggest that the ‘lots-of-rods’ phenotype is not conserved (data not shown). Of course, it
is possible and even likely that multiple factors converge to dictate rod versus cone cell
fate in the mouse, such as transcription factor expression, small molecule signaling, and
cell-cell interaction.

Nrl activity in the developing and adult retina
Once Nrl expression is established, it plays a critical role in the development and
maintenance of the rod phenotype.

Numerous studies have implicated Nrl as a

transcriptional activator of rod genes (Corbo et al., 2007), including the downstream
transcription factor Nr2e3 (Oh et al., 2008; Peng and Chen, 2005), rod pigment Rho
(Chen and Zack, 1996; Peng and Chen, 2011; Rehemtulla et al., 1996), signal
transduction protein Pde6b (Lerner et al., 2001), and myocyte enhancer Mef2c (Hao et
al., 2011). A recent Nrl ChIP-seq study in the mouse retina (Hao et al., 2012) has
identified many other genes whose promoter elements are bound by Nrl. This dataset
overlaps strongly with Crx binding data from a Crx ChIP-seq study (Corbo et al., 2010),
implying that many rod genes are co-regulated by Nrl and Crx. In addition to serving as
an important activator of rod genes, Nrl has also been shown to directly suppress cone
genes including the transcription factor Thrb and blue cone pigment Opn1sw (Oh et al.,
2007).
11

Other regulators of photoreceptor differentiation
Otx2, Crx, and Nrl may be the most extensively studied regulators of photoreceptor
differentiation, but numerous other transcription factors have also been shown to mediate
rod and cone development, including RORβ, Nr2e3, TRβ2 and Sall3.
RORβ is an orphan nuclear receptor with two known isoforms expressed in the
central nervous system (Andre et al., 1998; Schaeren-Wiemers et al., 1997); RORβ2 is
restricted to the pineal gland and retina (Andre et al., 1998). The Rorb null retina has a
dearth of rods and an excess of S-cones (Jia et al., 2009). However, these cones exhibit
late onset of S-opsin expression and lack outer segments (Jia et al., 2009; Srinivas et al.,
2006). RORβ functions upstream of Nrl during photoreceptor development, as Rorb null
retinas lack Nrl expression (Jia et al., 2009).

Since this gene appears to regulate

transcription in both rod and cone photoreceptors, however, its role in rod versus cone
determination is unclear.
Another orphan nuclear receptor, Nr2e3, originally caught the attention of
photoreceptor biologists when mutated copies of this gene were found in human patients
with enhanced S-cone syndrome (Haider et al., 2000). Later studies of rd7 mice lacking
functional Nr2e3 (Akhmedov et al., 2000; Chen et al., 2006) found that this rod-specific
transcription factor, like Nrl, can directly activate rod genes and repress cone genes
(Corbo and Cepko, 2005; Haider et al., 2009; Peng et al., 2005). Unlike the ‘true’ cones
of the Nrl null retina, however, Nr2e3 null photoreceptors appear to be rod-cone hybrids
that exhibit molecular and morphological characteristics of both cell types (Corbo and
Cepko, 2005; Webber et al., 2008). Moreover, a subset of cone genes appears to be
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regulated primarily by Nrl and not Nr2e3 (Corbo and Cepko, 2005). Thus, Nr2e3 is
thought to function downstream of Nrl in the development and maintenance of the rod
phenotype.
TRβ2 (Thrb) and Sall3 are two transcription factors important in the specification
of cone subtype. The mouse has two cone photopigments, medium-wavelength opsin
(M-opsin) and short-wavelength opsin (S-opsin) (Szel et al., 1992). These opsins are
expressed in a spatial gradient across the retina, with a higher localization of M-opsin
dorsally and greater S-opsin ventrally (Szel et al., 1992). Most S-opsin-expressing cones
also express M-opsin, although a small number of cones express S-opsin exclusively
(Haverkamp et al., 2005; Rohlich et al., 1994). In the Thrb null retina, M-opsin is
completely absent, and cones throughout the retina instead express S-opsin alone (Ng et
al., 2001). This suggests that developing cones default to the S-cone pathway and require
TRβ2 to turn on M-opsin (Ng et al., 2001).

In contrast, Sall3 appears to play an

important role in the regulation of S-opsin in the mouse: Sall3-null retinal explants have
reduced expression of S-opsin, and Sall3 overexpression by electroporation is sufficient
to induce ectopic S-opsin expression in wild-type retinas (de Melo et al., 2011).

Thus, decades of research have produced a detailed model for the development of the
vertebrate retina. Yet there are many areas of ongoing investigation regarding retinal
differentiation, including characterization of the retinal progenitor cell at the
transcriptional level (Blackshaw et al., 2004; Hafler et al., 2012), three dimensional
control of photoreceptor gene transcription in the nucleus (Peng and Chen, 2011),
epigenetic mechanisms involved in retinal development (Hackler et al., 2010; Merbs et
13

al., 2012; Nasonkin et al., 2011), and the generation of differentiated retinal cells from
embryonic stem cells (ESCs) or induced pluripotent stem cells (iPSCs) for the purpose of
treating disease (Lamba et al., 2010; Osakada et al., 2008; Pearson et al., 2012). I will
address the last area of research in the second part of this chapter by reviewing the history
of cellular reprogramming. I will also argue that our knowledge of factors involved in
retinal cell differentiation may be applied to a new therapeutic strategy for retinal disease:
direct conversion of one retinal cell type into another.

1.4

Reprogramming somatic cells: early experiments and iPSCs

In the 1950s, Conrad Waddington postulated that cellular differentiation occurs on an
epigenetic landscape composed of ridges and valleys (Waddington, 1957). He likened
the establishment of cell identity to a marble rolling downhill towards a final, stable state.
For several decades, the process of differentiation was thought to be irreversible.

Early experiments in cellular reprogramming
In 1983, Blau and colleagues performed the first experiment demonstrating that cells
could be induced to express previously silent genes (Blau et al., 1983): fusion of human
amniotic fibroblasts with mouse muscle cells produced a heterokaryon with stable
expression of muscle genes including myosin light chain and creatine kinase. Subsequent
heterokaryon experiments in different systems corroborated cell fusion as a means to
reprogram cellular phenotypes (Baron and Farrington, 1994; Baron and Maniatis, 1986;
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Bergman and Ringertz, 1990), and experimental heterokaryons are still generated today
to study the reestablishment of pluripotency (reviewed in Piccolo et al., 2011).
A second reprogramming breakthrough occurred in 1987, when Davis and
colleagues demonstrated that ectopic expression of a single myoblast cDNA, MyoD, was
sufficient to convert mouse embryonic fibroblasts into stable myoblasts (Davis et al.,
1987). MyoD was later shown to induce muscle gene expression in fibroblasts derived
from multiple tissue types, including nerve, fat, and liver (Weintraub et al., 1989). These
experiments established the power of a transcription factor to reprogram somatic cell
identities.

Induced pluripotent stem cells
In 2006, Takahashi and Yamanaka published a landmark study describing the conversion
of mouse fibroblasts into pluripotent stem cells by overexpression of four transcription
factors, Oct3/4, Sox2, c-Myc, and Klf4 (Takahashi and Yamanaka, 2006). These cells,
termed induced pluripotent stem cells or iPSCs, were able to give rise to many different
tissues when grafted into nude mice. The result was soon replicated in human fibroblasts
via two different transcription factor cocktails (Takahashi et al., 2007; Yu et al., 2007).
These studies launched a new field of research concerned with the generation and
controlled re-differentiation of iPSCs for therapeutic purposes (reviewed in Boucherie et
al., 2011; Dolmetsch and Geschwind, 2011; Robinton and Daley, 2012; Wu and
Hochedlinger, 2011), and stoked debate among scientists and the general public about the
continued study of human embryonic stem cells in the laboratory (Bilic and Izpisua
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Belmonte, 2012; Power and Rasko, 2011; Puri and Nagy, 2012; Zarzeczny and Caulfield,
2009).
While iPSCs are a promising source for customized cell-replacement therapies,
there are still numerous technical hurdles to overcome. First, fibroblast reprogramming
to the pluripotent state is inefficient and slow.

In their 2007 human iPSC paper,

Takahashi and colleagues reported successful reprogramming of 10 cells out of 5 x 104
originally transduced with the transcription factor cocktail, and emergence of ESC-like
properties required culture for 30 days (Takahashi et al., 2007). Many groups have
worked to improve the reprogramming efficiency by overexpressing additional factors
such as UTF1 (Zhao et al., 2008), knocking down factors like p53 and DNA
methyltransferase (Mikkelsen et al., 2008; Zhao et al., 2008), and treating cultures with
small molecules such as 5-azacytidine and valproic acid (Huangfu et al., 2008; Mikkelsen
et al., 2008) (reviewed in Feng et al., 2009).

Second, some factors used for

reprogramming, notably c-Myc, are oncogenic (reviewed in Eilers and Eisenman, 2008),
and iPSC tumorigenicity is a valid concern (Okita et al., 2007). Scientists have begun to
address this issue by searching for non-genetic methods for iPSC induction (Huangfu et
al., 2008; Shi et al., 2008). Third, iPSCs have been found to retain a ‘transcriptional
memory’ of their cell of origin, due in part to incomplete DNA methylation at isolated
loci (Kim et al., 2010; Ohi et al., 2011). This discovery has refreshed the debate of
whether iPSCs are truly equivalent to ESCs in terms of their differentiation potential
(Barrero and Izpisua Belmonte, 2011).
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1.5

Direct reprogramming of differentiated cells

The multitude of issues associated with iPSCs has refocused attention on an alternative
strategy for cell renewal: direct reprogramming of one somatic cell type into another,
without an intervening pluripotent state (reviewed in Chambers and Studer, 2011; Graf
and Enver, 2009; Vierbuchen and Wernig, 2011). Since the original MyoD experiments
of the 1980s, numerous investigators have achieved success in transcription factor-based
transdifferentiation of various cell types, both in vitro and in vivo.

B cells to T cells via a lymphoid progenitor
Transcriptional regulation of hematopoietic differentiation has been investigated for
decades, and scientists have discovered numerous factors controlling cell fate decisions
within this system (reviewed in Naito et al., 2011; Santos et al., 2011). One example is
Pax5, which promotes the commitment of lymphoid progenitors to the B cell pathway
(reviewed in Medvedovic et al., 2011). In 2007, Cobaleda and colleagues deleted Pax5 in
mature B cells, which resulted in dedifferentiation to the uncommitted lymphoid
progenitor state. These progenitors were then able to re-differentiate as functional T cells
in T-cell deficient mice (Cobaleda et al., 2007). This experiment demonstrated that
interconversion between closely related cell types is possible without complete reversion
to the pluripotent state.
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Pancreatic exocrine cells to β-cells
In 2007-2008, Zhou and colleagues identified transcription factors important for
pancreatic β-cell development (Zhou et al., 2007) and overexpressed them in mouse
pancreatic exocrine cells in vivo (Zhou et al., 2008). A combination of three factors,
Ngn3, Pdx1, and Mafa, was shown to induce direct reprogramming of exocrine cells into
insulin-secreting β-cells. These induced β-cells resembled islet β-cells morphologically
and molecularly, and were able to ameliorate hyperglycermia in diabetic mice (Zhou et
al., 2008).

An impressive 20% of transduced cells became insulin-positive, and

investigators detected reprogramming events after only 3 days.

This supports the

hypothesis that transdifferentiation between related cell types is more efficient than
reprogramming of iPSCs, possibly because the two cell types likely share many
epigenetic modifications (Zhou et al., 2008).

Fibroblasts to neurons
A common, direct lineage is not essential for successful somatic reprogramming, as
shown by recent experiments utilizing fibroblasts. In 2010, Vierbuchen and colleagues
were the first to achieve conversion of mouse fibroblasts into functional neurons
(Vierbuchen et al., 2010).

Starting with a pool of 19 genes important in neuronal

development and epigenetic reprogramming, investigators eventually isolated a set of just
three factors, Ascl1, Brn2, and Myt1l, that was sufficient to reprogram cultured
embryonic and tail fibroblasts to neuron-like cells. These cells expressed pan-neuronal
markers like NeuN and MAP2, formed functional synapses, and produced action
potentials in response to membrane depolarization (Vierbuchen et al., 2010). Other
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groups have since generated glutamatergic and dopaminergic neurons from both mouse
and human fibroblasts (Caiazzo et al., 2011; Pang et al., 2011; Yoo et al., 2011).

Fibroblasts to cardiomyocytes
Direct fibroblast reprogramming is possible in other systems as well. In 2010, Ieda and
colleagues successfully transformed cultured cardiac fibroblasts into cardiomyocytes via
three transcription factors, Gata4, Mef2c, and Tbx5 (Ieda et al., 2010). These factors
were isolated from an original pool of 14 factors using a screening approach similar to
that of Vierbuchen et al. (2010). The induced cardiomyocytes expressed cardiac-specific
proteins including α-actinin and atrial natriuretic factor, had similar epigenetic
modifications as normal cardiomyocytes at particular gene loci, and exhibited
spontaneous contraction (Ieda et al., 2010). Two years later, the same group reported that
cardiac fibroblasts could be directly converted into functional cardiomyocytes in vivo
(Qian et al., 2012).

These reprogrammed cells even more closely resembled true

cardiomyocytes than the previous in vitro-differentiated cells, possibly due to factors
provided by the native cardiac environment. The induced cardiomyocytes were even able
to produce modest attenuation of cardiac dysfunction in an infarct model (Qian et al.,
2012).

Thus, this experiment and the insulin-positive β-cell experiment provide

optimism for the treatment of human disease via direct, in vivo cellular reprogramming.
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1.6

Reprogramming and the treatment of retinal disease

Cellular regeneration is of particular relevance to the study of retinal disease. Mutations
in any one of more than 200 genes can result in retinal degeneration (Daiger, 1998),
leading to significant disability in millions of people (Sohocki et al., 2001).

Major obstacles in retinal gene replacement therapy
Gene replacement therapy has shown considerable promise for the prevention and
amelioration of inherited blindness in both model organisms and human patients
(reviewed in Liu et al., 2011; Montana and Corbo, 2008; Smith et al., 2009). However,
there are several barriers to the widespread adoption of gene replacement therapy in the
treatment of blindness. First, patients with advanced disease have often lost the majority
of their photoreceptors and thus may benefit only from some form of cell replacement
therapy (reviewed in Gaillard and Sauve, 2007; Stone, 2009). Second, the sheer diversity
of disease-causing mutations presents a daunting challenge for researchers, who must
design and validate delivery systems for each gene individually. Thus, there is a strong
motivation to develop gene-independent therapies that would be applicable to larger
families of disease (Farrar et al., 2002; Stieger and Lorenz, 2010). Third, dominant
alleles account for a large percentage of retinal disease (Daiger, 1998), and particularly of
retinitis pigmentosa (Farrar et al., 2010). Treatment of these patients will likely require
suppression of the mutated allele in addition to the delivery of a wild-type copy. While
this is theoretically possible via siRNA or other gene knockdown approaches (Farrar et
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al., 2002; O'Reilly et al., 2007), so far this technology has not been tested in humans or
even in larger model organisms such as canines.
To address the first obstacle, researchers have turned to ESCs and iPSCs as
sources for new photoreceptors, which might then be transplanted into patient retinas
(Lamba et al., 2010; MacLaren et al., 2006; Osakada et al., 2008; Pearson et al., 2012).
To address the second and third obstacles, I propose a new treatment model: direct
conversion of rod photoreceptors into cones, to bypass complications arising from rodspecific mutations.

The treatment of retinitis pigmentosa by direct reprogramming of rods into cones
Retinitis pigmentosa is the most common form of inherited retinopathy, with a
worldwide prevalence of approximately 1:3000-5000 (Chizzolini et al., 2011; Haim,
2002). It is often caused by mutations in rod-specific genes (Daiger, 1998), which result
in initial rod photoreceptor death and night blindness (Hartong et al., 2006). While this is
generally well tolerated by patients, the death of rods is often followed by secondary cone
degeneration (Hartong et al., 2006; Punzo et al., 2012), which leads to functionally
debilitating loss of daytime, color, and high acuity vision (Fig. 1.2).
The molecular mechanism driving secondary cone degeneration is currently an
open question. Growing evidence suggests, however, that loss of rods and collapse of the
retinal architecture generates a metabolic environment that is toxic to cones (Komeima et
al., 2006; Punzo et al., 2009; Punzo et al., 2012; Shen et al., 2005; Usui et al., 2009). In
this case, preservation of the ONL structure may be sufficient to foster cone survival. In
the second part of this thesis, I tested the hypothesis that primary rod cell death, due
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This would prevent

collapse of the ONL and secondary degeneration of endogenous cones, thus preserving
cone function.
Photoreceptors are highly specialized cell types and so far there has been no
evidence that they retain phenotypic plasticity following differentiation. However, rods
and cones share numerous molecular (Corbo et al., 2007), morphological (Carter-Dawson
and LaVail, 1979a), and functional (Luo et al., 2008) characteristics.

Also, their

specification during development appears to hinge on a single transcription factor, Nrl
(Mears et al., 2001). For these reasons, and also because of the success of transcription
factor-based reprogramming in other systems, we hypothesized that acute knockout of
Nrl in rod photoreceptors would elicit direct reprogramming to the cone phenotype.

In conclusion, the study of retinal development has evolved with an increased emphasis
on the molecular mechanisms underlying cellular differentiation and disease. The aim of
this thesis is two-fold: first, to elucidate factors governing the expression of the rod
photoreceptor determinant Nrl, and second, to manipulate this determinant for the
purpose of treating retinal disease.

Ultimately, this work seeks to further our

understanding of both the establishment and potential plasticity of the differentiated state.
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RORβ
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Cone genes
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Figure 1.1: The photoreceptor transcriptional network. Crx is a master regulator of
many photoreceptor genes, including transcription factors that govern rod and cone
differentiation. Nrl is necessary for the development of rod photoreceptors; it activates
rod genes including the transcription factor Nr2e3, while repressing cone genes.
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Figure 1.2: Typical progression of retinitis pigmentosa. Mutations in rod-specific
genes cause initial rod dysfunction and death, resulting in night blindness. Rod death
then leads to secondary cone dysfunction and death, with loss of central, color, and high
acuity vision.
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CHAPTER 2

Transcriptional regulation of Nrl by Crx, Otx2,
and RORβ
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2.1

Introduction

Nrl is a Maf-family transcription factor that is required for mouse rod photoreceptor
development (Mears et al., 2001). Nrl is expressed in the wild-type retina starting around
E12 (Akimoto et al., 2006), coincident with the beginning of the rod birth period (Cepko
et al., 1996; Young, 1985).

It subsequently activates numerous rod-specific genes

including Rhodopsin (Kumar et al., 1996; Rehemtulla et al., 1996) and many components
of the rod-specific phototransduction cascade (Corbo et al., 2007; Yoshida et al., 2004).
Nrl simultaneously represses cone genes in rods, either directly (Peng and Chen, 2005) or
by activating the downstream repressor Nr2e3 (Chen et al., 2005; Corbo and Cepko,
2005; Oh et al., 2008; Peng et al., 2005). In the Nrl null retina, rod gene expression fails
to initiate and rod precursors show a derepression of cone genes which results in a
transfating of the cells into cones in the adult retina (Daniele et al., 2005; Mears et al.,
2001).

Nrl expression is the earliest known marker of rod photoreceptor identity

(Akimoto et al., 2006), and expression persists at high levels in the outer nuclear layer
throughout adulthood (Hsiau et al., 2007). Not surprisingly, mutations in human NRL
often result in heritable retinal disease, most commonly autosomal dominant retinitis
pigmentosa (Daiger, 1998).
Despite the importance of Nrl in the photoreceptor transcriptional network as well
as in human disease, the mechanisms by which Nrl transcription is regulated are
incompletely understood. Akimoto and colleagues (2006) have shown that a 2.5-kb
region upstream of Nrl is sufficient to drive GFP expression in rod photoreceptors.
However, specific binding sites for transcriptional regulators within this promoter region
remain unknown. An earlier study of the Nrl promoter (Khanna et al., 2006) utilized a
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heterologous cell culture assay to identify promoter elements responsive to the rod fate
inducer retinoic acid (Kelley et al., 1994), but these sites have not yet been tested in vivo.
Nrl has also been hypothesized to be a regulatory target of other retinal transcription
factors such as Crx (Corbo et al., 2010; Hsiau et al., 2007) and RORβ (Jia et al., 2009),
but it is unclear whether this regulation is direct or indirect. In this study, we sought to
identify discrete cis-regulatory motifs and the transcription factors which bind them to
regulate activation of the Nrl promoter.
In order to conduct the Nrl promoter analysis in the living mouse retina, we
utilized a retinal explant electroporation assay (Matsuda and Cepko, 2004). This system
has been used previously to quantify the activity of photoreceptor-specific cis-regulatory
regions (Lee et al., 2010), and represents a much more realistic means of analyzing cisregulation than traditional mammalian cell culture approaches. Using this system, we
have found that three retinal transcription factors—Crx, Otx2, and RORβ—activate Nrl
transcription by binding directly to a highly conserved region of the Nrl promoter.

2.2

A 30-nucleotide region is critical for Nrl promoter activity

In order to identify the cis- and trans-acting factors required for regulation of Nrl, we
undertook a detailed analysis of its proximal promoter region.

A previous study

demonstrated that a 3.2-kb fragment of the mouse Nrl promoter (from -2345 to +865 bp
relative to the Nrl transcription start site) is sufficient to drive strong rod photoreceptorspecific expression in electroporated retinas (Matsuda and Cepko, 2007). This fragment
contains three blocks of high phylogenetic conservation (denoted P1, P2 and P3 in Fig.
2.1A) which correspond to regions bound by Crx in vivo as identified in a recent genome27

wide ChIP-seq study (Corbo et al., 2010).

We created a series of Nrl promoter

truncations to narrow down the minimal promoter region required for Nrl expression
(Fig. 2.1A). These promoter truncations were fused to the fluorescent reporter DsRed
and electroporated into P0 retinal explants along with the loading control pNrl(3.2 kb)GFP. The 3.2 kb and 2.9 kb constructs (both encompassing P1, P2 and P3) expressed
strongly in explant cultures after eight days (Fig. 2.1B). Interestingly, the 2.5 kb and 1.1
kb constructs that encompassed only P2 and P3 drove equally strong expression (Fig.
2.1B). Elimination of P2 in the 0.8 kb and 0.3 kb constructs, however, caused complete
loss of pNrl-DsRed expression, suggesting that P2 harbors cis-regulatory motifs critical
for Nrl expression.
To identify these motifs within the P2 block, we performed scanning mutagenesis
over a 160-bp region (Fig. 2.1C). Ten adjacent nucleotides were mutated at a time via
site-directed mutagenesis in the pNrl(1.1 kb)-DsRed construct. The promoter activity of
the 16 resultant constructs was then quantified by explant electroporation.

Most

mutations had relatively modest effects on promoter activity (Fig. 2.1C). However,
constructs 12, 13 and 14—encompassing a 30-nucleotide block immediately upstream of
the transcription start site—failed to drive any detectable DsRed expression. This 30nucleotide span was denoted the ‘critical region’ because of its indispensable role in Nrl
promoter activity.
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2.3

The critical region contains functional Crx and RORβ binding sites

Examination of the 30-nucleotide critical region revealed near-consensus binding sites for
two key photoreceptor transcription factors, Crx and RORβ, spaced seven nucleotides
apart (Fig. 2.2A). The Rorb gene encodes two transcript isoforms, RORβ1 and RORβ2
(Andre et al., 1998), which encode proteins with somewhat different DNA-binding
preferences. Whereas RORβ1 is widely expressed, RORβ2 is preferentially expressed in
photoreceptors and the pineal gland (Andre et al., 1998). Interestingly, the AGGTCA
core element of the putative RORβ site in the Nrl promoter's critical region is
immediately preceded by a thymidine nucleotide, which favors binding by the
photoreceptor-enriched isoform RORβ2 (Andre et al., 1998).
To test the functionality of these two sites within the pNrl(1.1 kb)-DsRed reporter,
we created point mutations predicted to abolish Crx binding (‘Crx mut’) or RORβ
binding (‘RORβ mut1’ and ‘RORβ mut2’) (Andre et al., 1998; Lee et al., 2010). All
three constructs resulted in a complete loss of expression in retinal explants (Fig. 2.2A).
Next, we tested whether the critical region has intrinsic promoter and/or enhancer activity
(Fig. 2.2B). To test promoter activity, we cloned the critical region (‘CR’) upstream of a
minimal basal promoter from bovine Rhodopsin which, by itself, does not drive any
expression in photoreceptors (Hsiau et al., 2007). This construct failed to drive DsRed in
explants (Fig. 2.2B, top panel). To determine whether the critical region could enhance
the activity of an adjacent active promoter, we cloned it upstream of a promoter fragment
from mouse Rhodopsin (‘Rho-prox’) which can drive moderate levels of DsRed
expression by itself (Fig. 2.2B, middle panel). Fusion of the critical region to Rho-prox
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markedly boosted DsRed expression (Fig. 2.2B, bottom panel). Thus, the critical region
lacks autonomous promoter activity but can act as a potent enhancer.
Lastly, we evaluated the relative contributions of the Crx and RORβ sites to the
critical region enhancer activity (Fig. 2.2C-D). Three new constructs were created on the
[critical region]-[Rho-prox]-DsRed backbone which eliminated the Crx site alone, the
RORβ site alone or both. These constructs were electroporated into retinal explants (Fig.
2.2C) and fluorescence levels were quantified (Fig. 2.2D). Mutation of the RORβ site
elicited a greater reduction in enhancer activity than the Crx site mutation, while mutation
of both sites caused an almost complete loss of critical region enhancer activity (Fig.
2.2D).

2.4

The conserved sequence upstream of the critical region contains additional
cis-motifs

With one exception, scanning mutagenesis of individual 10-bp blocks upstream of the
critical region (constructs 1 through 11) resulted in modest decrements in promoter
activity, in some cases down to ~50% of wild-type levels (Fig. 2.1C). This observation,
and the fact that this region is highly conserved phylogenetically, suggested that it might
contain multiple transcription factor binding sites that coordinately regulate promoter
activity. To test this idea, we engineered five additional truncations of the Nrl promoter
across this region and electroporated them into retinal explants as DsRed fusion
constructs (Fig. 2.3A-B).

As quantified in Fig. 2.3C, graded truncation of the Nrl

promoter correlated with graded loss of promoter activity (Fig. 2.3C). Thus, the 110-bp
sequence immediately upstream of the Nrl critical region is indispensable for Nrl
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promoter activity, despite the fact that no specific 10-bp block within the region is strictly
required for expression.

2.5

Coordinate regulation of Nrl by Crx and Otx2

Explant electroporation experiments determined that a putative Crx binding site is
essential for Nrl promoter activity. In addition, a prior study showed a marked decrement
in Nrl transcript levels in P28 Crx-/- retinas by in situ hybridization (Hsiau et al., 2007).
In order to determine the temporal dependence of Nrl expression on Crx, we measured
Nrl transcript levels across developmental time in wild-type and Crx-/- retinas (Fig. 2.4A).
Reverse transcription quantitative PCR (RT-qPCR) showed that Nrl transcript levels are
similar in wild-type and Crx-/- retinas until P7, after which the levels fall off sharply in
Crx-/- compared to wild-type (Fig. 2.4A). This result suggests that Crx is not required for
the initiation of Nrl expression in vivo, but that it is necessary for maintenance of Nrl
transcription at later timepoints. In a second experiment, we co-electroporated pNrl(3.2
kb)-DsRed and control pCAG-GFP into P0 wild-type and Crx-/- retinal explants. After
ten days in culture, pNrl(3.2 kb)-DsRed expression was moderately reduced in Crx-/explants relative to wild-type (Fig. 2.4B), confirming that Crx plays only a minor role in
activating the Nrl promoter in the early postnatal period.
These two results are seemingly at odds with the observation that mutation of a
single putative Crx binding site within the critical region completely abolishes Nrl
promoter activity in electroporated retinas in the early postnatal period (Fig. 2.2A). In
order to account for this discrepancy, we hypothesized that the retinal transcription factor
Otx2 might be able to compensate for Crx at early timepoints. Otx2 and Crx are both
31

K50 homeodomain transcription factors required for photoreceptor development (Chen et
al., 1997; Furukawa et al., 1997; Nishida et al., 2003), and they have nearly identical
DNA-binding preferences (Chatelain et al., 2006; Lee et al., 2010). In addition, Otx2 is
required for initiation of Crx expression (Nishida et al., 2003). Otx2 and Crx are both
expressed at high levels in differentiating photoreceptors through P3.5 (Fig. 2.4C). By
P10.5, however, Otx2 levels have decreased in photoreceptors while Crx levels remain
high (Fig. 2.4C). At the adult stage, expression of Otx2 persists in photoreceptors at only
very low levels whereas Crx is maintained at high levels (Hsiau et al., 2007). Thus, it is
reasonable to surmise that both Otx2 and Crx may bind to the Nrl promoter critical region
in the early postnatal period to activate Nrl transcription. As photoreceptor Otx2 levels
decline later, Crx may become the predominant activator of Nrl.
To test the hypothesis that both Crx and Otx2 activate the Nrl promoter in the
early postnatal period, we performed a series of explant electroporations utilizing retinas
from the Otx2f/f mouse which is homozygous for a conditional ('floxed') allele of Otx2
(Fig. 2.4D). Electroporation of pNrl(3.2 kb)-DsRed and control pCAG-GFP into Otx2f/f
explants resulted in strong DsRed expression after ten days (Fig. 2.4D, first panel). To
eliminate Crx alone, we co-electroporated a Crx RNAi construct (Matsuda and Cepko,
2004) along with the fluorescent reporters which resulted in a decrease in pNrl-DsRed
expression (Fig. 2.4D, second panel). Interestingly, the decrease in expression was
greater than what was observed when the pNrl-DsRed construct was electroporated into
Crx-/- retinas (Fig. 2.4B). This difference might be explained by the fact that in the Crx-/retina, there is ~2-fold increase in Otx2 expression (Hsiau et al., 2007). Thus, in the
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acute RNAi-mediated knockdown of Crx, there may be insufficient time for
compensatory Otx2 upregulation.
To acutely knockout Otx2 alone, we co-electroporated a plasmid encoding Cre
recombinase along with the fluorescent reporters and again observed decreased pNrlDsRed expression (Fig. 2.4D, third panel). Since initiation of Crx expression depends on
Otx2 (Nishida et al., 2003), one might expect that knockout of Otx2 would result in loss
of both Otx2 and Crx. However, some residual expression of the DsRed reporter was still
apparent in photoreceptors when Otx2 was knocked out (Fig. 2.4D, third panel). We
therefore hypothesized that there may be some perdurance of Crx transcripts in the Otx2
knockout. Thus, to decrease Crx and Otx2 transcript levels simultaneously, we coelectroporated both Crx RNAi and Cre recombinase. This dual knockdown approach
reduced pNrl-DsRed expression to nearly undetectable levels (Fig 2.4D, fourth panel),
supporting our hypothesis that Crx and Otx2 are both necessary for activation of the Nrl
promoter during rod photoreceptor development.

In addition, these findings are

consistent with the idea that both Crx and Otx2 mediate Nrl activation by binding to the
'Crx' site present in the critical region.

2.6

Otx2, Crx, and RORβ bind directly to the Nrl promoter

Next, we wished to determine whether Otx2, Crx and RORβ bind the bioinformatically
identified sites within the critical region of the Nrl promoter. First, we performed an
electrophoretic mobility shift assay (EMSA) with biotinylated probes containing the
sequence of the critical region (Fig. 2.5). Recombinant proteins consisting of the DNA
binding domains of Otx2, Crx and RORβ were purified, mixed with the probes, and run
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on a non-denaturing gel. Otx2 and Crx protein were both able to shift the biotinylated
probe containing the wild-type critical region sequence (Fig. 2.5, top two panels, third
row), and the shift was eliminated by non-biotinylated competitor probe (fourth row).
Mutation of the Crx site alone completely abolished the shift (fifth row); mutation of the
RORβ site alone did not affect the shift (sixth row); and mutation of both the Crx and
RORβ sites again abolished the shift (seventh row). Likewise, RORβ was able to shift
the wild-type probe (bottom panel, third row) and the probe containing a Crx mutation
(fifth row) but was unable to shift the probes containing mutations of the RORβ site
(sixth row) or RORβ and Crx sites (seventh row). This result indicates that Otx2, Crx
and RORβ bind strongly and specifically to their cognate sites in the Nrl critical region in
vitro.
To test whether Otx2, Crx and RORβ bind to the Nrl critical region in vivo, we
performed a chromatin immunoprecipitation experiment utilizing mouse retinal tissue
isolated at three postnatal timepoints. Antibodies to Otx2 and Crx produced enrichment
of the Nrl critical region at all three timepoints, with peak Otx2 binding at P3 and peak
Crx binding at P7 (Fig. 2.6). As a control, the promoter of the microglial gene Tyrobp—
which is not predicted to bind either Crx or Otx2—was not enriched. Two different
polyclonal antibodies against RORβ did not show enrichment of the critical region (data
not shown). However, these antibodies also failed to show enrichment of the blue cone
opsin promoter region which has previously been shown to be a direct target of RORβ
(Srinivas et al., 2006). Thus, the absence of enrichment at the Nrl promoter in this case is
likely attributable to the inability of these antibodies to immunoprecipitate their target.
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2.7

Discussion

In this study, we have shown that Otx2, Crx and RORβ directly regulate Nrl expression
in developing mouse rod photoreceptors. Binding sites for these factors reside in a highly
conserved region immediately upstream of the Nrl transcription start site, and directed
point mutations in these sites are sufficient to completely abolish pNrl-DsRed expression
in mouse retinal explants. EMSA experiments confirm direct binding of Otx2, Crx and
RORβ at this region of the Nrl promoter. Direct binding of Otx2 and Crx was further
validated in ChIP experiments with mouse retinal lysates. While the present paper was
under preparation, a report appeared which corroborates our findings with respect to the
regulation of the Nrl promoter by RORβ (Kautzmann et al., 2011).
An interesting conclusion from our experiments was the functional redundancy of
Crx and Otx2 in the activation of Nrl transcription during the late embryonic and early
postnatal periods.

Both Otx2 and Crx are required for photoreceptor cell fate

determination (Chen et al., 1997; Furukawa et al., 1999; Nishida et al., 2003), but since
Otx2 is required for initiation of Crx transcription (Nishida et al., 2003), it is difficult to
distinguish the roles of these two transcription factors in the regulation of specific genes.
A study utilizing the Otx2+/CKO; Crx-/- double knockout suggested that Otx2 itself is an
active regulator of certain photoreceptor genes in the early postnatal period, such as Rho
and Pde6b (Koike et al., 2007). In the present study, we demonstrated by ChIP that Otx2
and Crx are both bound at the Nrl promoter at P3, P7 and P21.

Moreover, Otx2

activation of Nrl can partially compensate for the loss of Crx in the first postnatal week,
whereas loss of both Otx2 and Crx results in a dramatic loss of Nrl promoter activation.
Our findings suggest the following model for the initiation and maintenance of Nrl
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transcription (Fig. 2.7).

During the initiation phase, Otx2 and RORβ are the main

activators of the Nrl promoter. In the later maintenance phase, however, Crx supplants
Otx2 as the main activator of Nrl transcription.
While our analysis has identified two critical cis-regulatory motifs in the Nrl
promoter, there are undoubtedly a number of other important regulatory sites that remain
unknown. For example, the 110-base pair region upstream of the critical region likely
contains binding sites for multiple transcription factors that may act synergistically to
activate Nrl expression.

We found that disruption of individual sites via scanning

mutagenesis is not sufficient to abolish Nrl promoter activity, whereas elimination of the
entire 110-bp region causes total loss of activity. A couple low-affinity Crx sites are
present in this region and may play a role in activation (data not shown). It is possible
that binding sites for other factors are also present.
Retinoic acid has long been known to foster rod photoreceptor differentiation
(Hyatt et al., 1996; Kelley et al., 1994), thus retinoic acid receptors represent attractive
candidate regulators of Nrl expression.

Several years ago, Khanna and colleagues

identified three elements within the Nrl promoter region that appear to be sensitive to
retinoic acid in a heterologous tissue culture assay system (Khanna et al., 2006). We
sought to test the importance of these putative retinoic acid response elements (RAREs)
in living mouse retinas by mutating each RARE individually in the context of the
pNrl(1.1 kb)-DsRed reporter. Mutation of the individual RAREs resulted in only modest
changes in DsRed expression relative to the non-mutated control (Figure 2.8). Therefore,
while these sites might contribute to the modulation of Nrl expression in vivo, they are
not individually required for activation of the Nrl promoter.
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A recent Crx ChIP-seq study found that many photoreceptor genes are surrounded
by a spatially distributed network of Crx-bound regions which are hypothesized to act in
a combinatorial fashion to regulate expression of their associated gene (Corbo et al.,
2010). The Nrl gene also appears to follow this pattern since a total of four highly
conserved noncoding regions which correspond to Crx ChIP-seq peaks were identified
around the locus: P1, P2, P3 and an element within the 3rd intron (Fig. 2.1A). The initial
promoter truncation analysis demonstrates that the P1 element is not critical for Nrl
promoter activation, but P1 may be involved in fine-tuning of Nrl expression levels in
rods. In addition, the P1 element may also contribute to maintenance of normal levels of
Nrl expression at later developmental timepoints and in the adult.
The roles of the P3 region and the intronic element also remain to be explored.
Preliminary bioinformatic analyses identified a potential Crx site in the P3 region, but
point mutation of this site in the context of the full-length pNrl(3.2 kb)-DsRed resulted in
only minimal changes in expression (data not shown). It is possible that this region and
the intronic element play a role in modulating Nrl expression outside the time window
assayed in the present study.
The close proximity of the Otx2/Crx and RORβ binding sites in the Nrl promoter
critical region is note-worthy.

We previously showed that clusters and pairs of

transcription factor binding sites, often within 50 bp of one another, are present in many
photoreceptor cis-regulatory regions (Corbo et al., 2010; Hsiau et al., 2007). In fact, as
few as three closely clustered Crx sites in the context of a synthetic cis-regulatory
element are sufficient to drive photoreceptor-specific expression in electroporated retinas
(Corbo et al., 2010). Many endogenous photoreceptor cis-regulatory regions, however,
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appear to be comprised of clusters of both Crx sites and other sites for factors such as Nrl,
Nr2e3 and bHLH factors such as NeuroD1 (Corbo et al., 2010; Liu et al., 2008; Peng and
Chen, 2005). Thus, the paired Otx2/Crx-RORβ motif identified in the present study
obeys the usual logic of photoreceptor cis-regulatory grammar.
In conclusion, we have identified three transcription factors—Otx2, Crx and
RORβ—that control Nrl expression by direct binding to the Nrl promoter. Although all
three of these factors are present in both rods and cones and are required for gene
expression in both cell types (Chen et al., 1997; Furukawa et al., 1997; Hsiau et al., 2007;
Jia et al., 2009; Koike et al., 2007; Nishida et al., 2003; Srinivas et al., 2006), antibody
and misexpression studies indicate that Nrl is likely restricted to rods (Oh et al., 2007;
Swain et al., 2001). How then is the rod-specific pattern of Nrl expression established?
One possibility is that a yet-undiscovered rod-specific transcription factor functions
upstream of Nrl and coordinates with Otx2, Crx and/or RORβ to activate Nrl
transcription exclusively in rods. Alternatively, it is possible that there exists a conespecific transcription factor X which acts as a repressor of Nrl and thereby restricts its
expression to rods. If Nrl were to reciprocally repress factor X's expression in rods, then
the two factors could act together as a poised binary switch between rod and cone cell
fate similar to what has been observed in a number of systems (Graf and Enver, 2009).
Whereas knockout of Nrl results in a transfating of rods into UV-sensitive cones (Mears
et al., 2001), knockout of factor X would be predicted to result in the converse
phenotype. A recent study in zebrafish has identified such a factor: loss of Tbx2b results
in a 'lots of rods' phenotype in which UV cones are converted into rods (Alvarez-Delfin et
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al., 2009). It will be extremely interesting to determine whether an analogous factor
exists in mammalian retinas.

2.8

Materials and methods

Mouse husbandry
Adult cd1, C57BL/6, Crx-/- (Furukawa et al., 1999) and Otx2f/f (Tian et al., 2002) mice
were maintained on a 12-hour light-dark schedule at 22oC with free access to food and
water. The Otx2f/f mutant (Acc. No. CDB0013K) was obtained as described (Tian et al.,
2002). The health of the animals was regularly monitored. All studies were conducted in
accordance with the Guide for the Care and Use of Laboratory Animals and the Animal
Welfare Act and were approved by the Washington University in St. Louis Institutional
Animal Care and Use Committee (approval no. 20110089).

DNA constructs
The pNrl(3.2 kb)-DsRed and pCAG-GFP vectors have been previously described
(Matsuda and Cepko, 2004, 2007). pNrl(3.2 kb)-GFP was created by replacing the
DsRed coding sequence in pNrl(3.2 kb)-DsRed with GFP, using the EcoRI and NotI
restriction sites.
To create the Nrl promoter truncation constructs in Fig. 2.1, PCR was used to
amplify the following regions of the mouse Nrl promoter relative to the transcription start
site (RefSeq NM_001136074): pNrl(2.9 kb), -2063 to +865; pNrl(2.5 kb), -1695 to
+865; pNrl(1.1 kb), -202 to +865; pNrl(0.8 kb), +35 to +865; and pNrl(0.3 kb), +549 to
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+865. The promoter fragments were subcloned upstream of DsRed in the no-basal vector
(Hsiau et al., 2007) using the XbaI and SmaI restriction sites.
Scanning mutagenesis constructs were created via site-directed mutagenesis of
pNrl(1.1 kb)-DsRed. The QuikChange II XL Site-Directed Mutagenesis kit (Agilent,
Santa Clara, CA) was used with the primers listed in Table 2.1 (both sense and antisense
primers were added to the mutagenesis PCR reaction although only sense primers are
listed). In general, G ↔ T and C ↔ A substitutions were made unless mutagenesis
generated a Crx binding site (constructs #8 and #12), in which case the de novo site was
disrupted by an alternative substitution. Site-directed mutagenesis was also used to
create one- or two-nucleotide mutations in the Crx and RORβ binding sites within the
pNrl(1.1 kb)-DsRed vector, and to mutate the retinoic acid response elements as shown in
Figure 2.8.
To create the CR-DsRed construct, the following oligos containing the Nrl critical
region were kinased and annealed (restriction site-compatible ends underlined): 5’ctagagttaggcgattaggctgaaaatgtaggtcacacccggtac-3’ and 5’-cgggtgtgacctacattttcagcctaatcgcctaact-3’, and the resultant product was subcloned upstream of DsRed in the Rhobasal vector (Hsiau et al., 2007) with the XbaI and KpnI restriction sites. To create [Rhoprox]-DsRed, a 205-nucleotide region of the mouse Rho promoter was obtained by PCR
from mouse genomic DNA using the following primers: 5’-gtactctagaatgtcaccttggcccctc3’ and 5’-gtacggtaccgacagagaccaaggctgct-3’. This product was digested with XbaI and
KpnI and subcloned upstream of DsRed in the no-basal vector. [CR]-[Rho-prox]-DsRed
and mutation-containing variants (Fig. 2.2C) were created by subcloning CR-containing
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oligonucleotides into the [Rho-prox]-DsRed vector with the restriction sites SalI and
XbaI.
To create the Nrl promoter truncation constructs in Fig. 2.3, PCR was used to
amplify the following regions of the mouse Nrl promoter relative to the transcription start
site: pNrl(0.99 kb), -122 to +865; pNrl(0.97 kb), -102 to +865; pNrl(0.95 kb), -82 to
+865; and pNrl(0.92 kb), -57 to +865. The promoter fragments were subcloned upstream
of DsRed in the no-basal vector (Hsiau et al., 2007) using the XbaI and SmaI restriction
sites.
Two non-fluorescent DNA constructs were electroporated in this study. The Crx
RNAi construct has been previously described in Matsuda and Cepko (2004). pNrl(1.1
kb)-Cre was created by subcloning the Cre coding sequence from pCAG-Cre (Matsuda
and Cepko, 2007) in place of DsRed in the pNrl(1.1 kb)-DsRed vector, using the
restriction sites EcoRI and NotI.

Electroporation and culture of explanted retinas
Electroporation and explant culture of mouse retinas were performed as previously
described (Hsiau et al., 2007). Briefly, eyes were removed from decapitated P0 mouse
pups and the retinas were dissected leaving the lens in place. The retinas were then
electroporated in a DNA solution consisting of the experimental DsRed reporter construct
and a control GFP reporter construct, each at a final concentration of 0.5 μg/μl.
Following the explant culture period, retinas were fixed, whole-mounted for quantitative
imaging, and embedded for cryosectioning as previously described (Lee et al., 2010).
Wild-type cd1 mice were used unless otherwise stated.
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Quantitation of promoter activity in whole-mount retinas
DsRed fluorescence levels were measured and normalized to control GFP values as
described previously (Lee et al., 2010).

Briefly, 8-9 whole-mounted electroporated

retinas for each reporter construct were imaged at 400X magnification under
epifluorescent illumination. Images were captured in both the red and green channels
using a monochromatic camera (ORCA-ER; Hamamatsu, Japan). Circles of interest were
defined and mean pixel values were recorded for five regions overlying the
electroporated retina and three control regions outside the retina (for background
subtraction) in both the red and green channels using ImageJ software (NIH, Bethesda,
MD).

For normalization, the background-subtracted mean pixel value of the

experimental red channel was divided by the background-subtracted mean pixel value of
the control green channel. Standard deviation was calculated based on all normalized
fluorescence measurements (five measurements per retina, 8-9 retinas per construct).

Reverse transcription quantitative PCR for the Nrl transcript
Retinal tissue was isolated from wild-type (C57BL/6) and Crx-/- mice (on a C57BL/6
background). Three biological replicates (3-4 retinas each) were collected for each time
point. Total RNA was extracted using TRIzol (Invitrogen, Carlsbad, CA) and quantified
using a Nanodrop device (Thermo Fisher Scientific, Waltham, MA).

cDNA was

synthesized using the Superscript III First-Strand Synthesis System for RT-PCR
(Invitrogen, Carlsbad, CA) with 1 μg total RNA and oligo(dT)20 primers.

Reverse

transcription quantitative PCR (RT-qPCR) was performed using SYBR-Green (Applied
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Biosystems, Carlsbad, CA) and the following primers (Cicero et al., 2009):

Nrl

transcript, 5’-aacttctgagcatcgtggca-3’ and 5’-tgaagagtcgtgacctgcaaa-3’; Gapdh transcript,
5’-ctccactcacggcaaattca-3’ and 5’-cgctcctggaagatggtgat-3’.

Three technical replicate

PCRs were performed for each biological replicate. For each biological replicate, Nrl
transcript levels were normalized to control Gapdh levels (ΔCt). ΔCt values from the
three biological replicates were then averaged and fold-change relative to the wild-type
P7 Nrl expression level was calculated, along with the standard deviation across the
biological replicates.

Electrophoretic mobility shift assay (EMSA)
The DNA binding domains of Otx2 and Rorb were amplified from mouse retinal cDNA
using the following PCR primers: Otx2, 5’-ttcgggaattccagcgaagggagaggacga-3’ and 5’tcaggcggccgcctgctgttggcggcacttag-3’; Rorb, 5’-ttcgggaattcatgtgtgagaaccagcc-3’ and 5’tcaggcggccgcagcctttgctgatgcttctg-3’. The products were digested with EcoRI and NotI
and subcloned into the pGEX-5X-1 vector (Amersham/GE Healthcare, Piscataway, NJ)
to generate an N-terminal GST fusion. A third GST fusion vector containing the DNA
binding domain of Crx has been previously described (Lee et al., 2010). The vectors
were transformed into the Escherichia coli strain BL21 and recombinant protein was
generated, purified and concentrated as previously described (Lee et al., 2010).
Sense and antisense oligonucleotides were biotinylated with the Biotin 3’ End
DNA Labeling Kit (Pierce Biotechnology, Rockford, IL) per the manufacturer’s
instruction and annealed. For Crx and Otx2, DNA binding reactions were carried out at
25oC for 1 hour in the following 20-μl reaction mixture: 1 μl recombinant protein, 1
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fmol/μl biotinylated probe, 60 mM KCl, 25 mM HEPES (pH 7.6), 1 mM DTT, 1 mM
EDTA, 5% glycerol. For RORβ, binding reactions were carried out at 25oC for 1 hour in
the following 20-μl reaction mixture:

1X binding buffer (Pierce Biotechnology,

Rockford, IL), 2.5% glycerol, 5 mM MgCl2. Unlabeled, annealed competitor oligos were
added to control reactions at a final concentration of 0.2 pmol/μl (200-fold molar excess
relative to labeled probe).

The binding reactions were run on a 10% TBE native

polyacrylamide gel (Invitrogen, Carlsbad, CA) at 100 V for 30 minutes. Transfer to a
nylon membrane, cross-linking of DNA to the membrane, blocking, incubation with
streptavidin-horseradish

peroxidase

conjugate,

washing

and

chemiluminescent

development were performed as directed by the LightShift Chemiluminescent EMSA Kit
(Pierce Biotechnology, Rockford, IL).

Chromatin immunoprecipitation (ChIP)
ChIP assays were performed as previously described (Corbo et al., 2010) with minor
modifications. Briefly, 6-8 retinas were isolated from cd1 mice at each timepoint for
each biological replicate (two biological replicates per timepoint, per antibody). Pooled
retinas were cross-linked with 1% formaldehyde for 15 minutes at room temperature; the
reaction was stopped by addition of glycine to a final concentration of 0.125 M.
Crosslinked retinas were mechanically dissociated with a mortar and pestle and lysed in
0.5% NP-40. The nuclear pellet was lysed with 1% SDS and 0.5% EmpigenBB and
homogenized by sonication, 35-50 x 10 sec. at 25% amplitude (VibraCell; Sonics,
Newtown, CT), to a chromatin fragment size range of 200-500 bp. Immunoprecipitation
of sheared chromatin was performed overnight at 4oC with 2.5 μg anti-Crx antibody
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(Santa Cruz, sc-30150X) or 2.5 μg anti-OTX2 antibody (Millipore, AB9566). Control
precipitations were also carried out with 2.5 μg rabbit IgG (Santa Cruz, sc-2027) for each
biological replicate.

Chromatin-antibody complexes were incubated with protein G

Dynabeads (Invitrogen, Carlsbad, CA) for 2 hours at 4oC. After washing and elution
steps, crosslinks were reversed at 65oC overnight. The immunoprecipitated DNA was
purified using QIAquick purification columns (Qiagen, Valencia, CA).
Quantitative real-time PCR (qPCR) was performed on immunoprecipitated,
purified DNA using SYBR Green (Applied Biosystems, Carlsbad, CA) with the
following primers:
tctcctctctcgctcattcc-3’;

Nrl critical region, 5’-cctactagggggtgacagctc-3’ and 5’Tyrobp

control,

5’-tctttctgcggccatgtcta-3’

and

5’-

tgtgacgtccaaccaagtgaa-3’. Three technical replicate PCRs were performed for each of the
two biological replicates. The fold enrichment of each target was calculated as 2 to the
power of the cycle threshold (Ct) difference between IgG- and Crx-ChIP or IgG- and
Otx2-ChIP.

RNA in situ hybridization (ISH)
ISH on retinal tissue sections was performed as previously described (Chen and Cepko,
2000). Briefly, either whole eyes or retinas were isolated from C57BL/6 mice at various
timepoints.

The tissue was fixed in 4% paraformaldehyde at 4oC overnight, then

equilibrated in 30% sucrose/PBS and embedded in OCT (Tissue Tek). The embedded
tissue was cryosectioned, mounted on glass slides, and hybridized with RNA riboprobes
synthesized from PCR products derived from templates described in previous studies
(Corbo et al., 2007; Hsiau et al., 2007).
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Figure 2.1: Identification of a short, conserved region critical for Nrl promoter
activity. (A) The fluorescent reporter DsRed was fused downstream of six different Nrl
promoter truncations, ranging from 3.2 kb to 0.3 kb, based on blocks of phylogenetic
conservation (P1, P2 and P3; UCSC Genome Browser Phastcons track shown) (Rhead et
al., 2010) and previously published Crx ChIP-seq data (each black tick mark represents
one sequence read) (Corbo et al., 2010). (B) pNrl-DsRed truncation constructs were
electroporated along with the pNrl(3.2 kb)-GFP loading control into retinas dissected
from P0 mice. After eight days in explant culture the retinas were fixed and imaged in
flatmount. While the 3.2 kb, 2.9 kb, 2.5 kb and 1.1 kb promoter truncations all drove
similarly strong levels of DsRed expression, the 0.8 kb and 0.3 kb truncations failed to
drive DsRed expression. DsRed expression was restricted to the outer nuclear layer for
all constructs tested, as demonstrated in the cross-section of a retinal explant
electroporated with pNrl(3.2 kb)-DsRed and ubiquitously expressing pCAG-GFP (bottom
panel).

(C) Scanning mutagenesis was performed on a 160-bp region within the
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phylogenetically conserved block P2: using the pNrl(1.1 kb)-dsRed construct as the
vector backbone, 10 adjacent nucleotides of the P2 block were mutated at a time via sitedirected mutagenesis (G ↔ T, A ↔ C). The 16 constructs were co-electroporated with
pNrl(3.2 kb)-GFP into P0 retinas, grown in explant culture for eight days, and imaged in
flatmount.

pNrl(1.1 kb, mutated)-DsRed expression, relative to pNrl(3.2 kb)-GFP

expression, was quantified and normalized to wild-type pNrl(1.1 kb)-dsRed expression
(‘Ctrl’).

Constructs 12, 13 and 14—encompassing 30 nucleotides total of the Nrl

promoter—failed to drive DsRed expression. Error bars, s.d.
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Figure 2.2: Mutation of putative Crx and RORβ binding sites abolishes the activity
of the Nrl promoter critical region. (A) The critical region contains bioinformatically
predicted binding sites for both Crx and RORβ. pNrl(1.1 kb)-DsRed constructs were
created that contain point mutations predicted to abolish Crx binding (‘CRX mut’) or
RORβ binding (‘RORβ mut1’ and ‘RORβ mut2’). All three mutant constructs failed to
express in retinal explants. (B) The critical region was isolated and fused to a basal
promoter (123 nucleotides from the bovine Rhodopsin promoter) and DsRed but failed to
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drive DsRed expression (top panel). The critical region was also fused to the short
promoter Rho-prox (205 nucleotides from the mouse Rhodopsin promoter). While Rhoprox can autonomously drive moderate DsRed expression (middle panel), fusion of the
critical region with Rho-prox greatly boosts DsRed expression (bottom panel). (C) Point
mutations predicted to abolish binding of Crx; RORβ; or Crx and RORβ caused graded
loss of promoter activity of the [critical region]-[Rho-prox]-DsRed construct.

(D)

Quantification of DsRed fluorescence of the constructs shown in part (C), normalized to
[Rho-prox]-DsRed (‘No CR’). Error bars, s.d.

49

Figure 2.3: Graded truncation of the Nrl promoter upstream of the critical region
correlates with graded loss of promoter activity. (A) Four additional Nrl promoter
truncations—0.99 kb, 0.97 kb, 0.95 kb and 0.92 kb—were fused to DsRed and
electroporated into retinal explants. Note that the 1.07 kb promoter was referred to as
‘1.1 kb’ In Figures 2.1 and 2.2. (B) Progressive truncation of the promoter region
immediately upstream of the critical region correlated with graded loss of promoter
activity. (C) Quantification of DsRed fluorescence of the constructs shown in parts (A)
and (B), normalized to pNrl(1.07 kb)-DsRed. Error bars, s.d.
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Figure 2.4: Crx and Otx2 coordinately regulate Nrl expression in the developing
mouse retina. (A) Reverse transcription quantitative PCR (RT-qPCR) analysis of Nrl
transcript levels in C57BL/6 wild-type mice (blue line) and Crx null mice (orange line).
Error bars represent standard deviation across three biological replicates. (B) Wild-type
and Crx null retinas were co-electroporated with pNrl(3.2 kb)-DsRed and the pCAG-GFP
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loading control and cultured for ten days. DsRed expression was modestly reduced in
Crx-/- retinas compared to wild-type. (C) in situ hybridizations for the Otx2, Crx and Nrl
transcripts in wild-type retinas at various developmental timepoints. The E14.5, P3.5 and
P10.5 Crx images have been previously published (Hsiau et al., 2007) and are reproduced
here for the sake of comparison.

Note that Crx and Otx2 possess nearly identical

expression patterns in the retina from E12.5 through P3.5, with the exception that Otx2 is
also expressed in the retinal pigment epithelium. However, after P3.5, Otx2 levels
diminish in the outer nuclear layer while high Crx levels are sustained. The orange arrow
at P10.5 denotes persistent, high-level Otx2 expression in bipolar cells of the inner retina.
(D) Retinas from homozygous Otx2 floxed mice (Otx2 f/f) were co-electroporated with
pNrl(3.2 kb)-DsRed and the pCAG-GFP and cultured for ten days. Retinas that were
additionally electroporated with Crx RNAi (2nd panel from left) or a Cre recombinaseencoding plasmid (3rd panel from left) showed a reduction in pNrl(3.2 kb)-DsRed
expression.

Retinas that received both Crx RNAi and Cre recombinase (4th panel)

showed nearly undetectable levels of pNrl(3.2 kb)-DsRed. Note that the fluorescence
enclosed by the white dotted lines indicates lens autofluorescence. Residual DsRed
expression in photoreceptors is indicated by white arrows.
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Figure 2.5: Electrophoretic mobility shift assay (EMSA) shows that Otx2, Crx and
RORβ are capable of binding to the critical region in vitro. Recombinant GST fusion
proteins containing the DNA-binding domains of Otx2 (top panel), Crx (middle panel)
and RORβ (bottom panel) were mixed with 35 bp biotinylated probes containing the Nrl
promoter critical region (indicated at the bottom). All three proteins caused a shift of the
probe containing the wild-type sequence (Probe A), and this shift was eliminated by the
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addition of unlabeled competitor probe (200-fold molar excess). A probe containing
mutations in the Crx site (Probe B) was shifted by RORβ protein but not by Otx2 or Crx
protein. A probe containing mutations in the RORβ site (Probe C) was shifted by Otx2
and Crx protein but not by RORβ protein. A probe containing mutations in both the Crx
and RORβ sites was not shifted by any of the three proteins.
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Figure 2.6: Chromatin immunoprecipitation (ChIP) demonstrates binding of Otx2
and Crx to the critical region in vivo. ChIP was performed on retinal tissue isolated at
P3, P7 and P21 utilizing antibodies to Otx2 (top panel) and Crx (bottom panel).
Quantitative real-time PCR was performed to measure enrichment at the Nrl critical
region (‘Nrl CR’) and a negative control region not predicted to bind Otx2 or Crx
(‘Tyrobp’). Error bars represent standard deviation between two biological replicates.
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Figure 2.7: Model for coordinate regulation of Nrl by transcription factors Otx2,
Crx and RORβ. Otx2, Crx and RORβ are hypothesized to contribute to Nrl expression
in the early ‘initiation’ phase, with Otx2 and RORβ playing a particularly important role
(as indicated by bold arrows). During the later ‘maintenance’ phase of Nrl expression,
Crx becomes a more important activator of Nrl as Otx2 levels decline in photoreceptors.
Prior studies have suggested that Crx transcriptionally autoregulates.
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Figure 2.8:

Mutation of previously identified retinoic acid response elements

(RAREs) in the Nrl promoter results in minor changes in pNrl(1.1 kb)-DsRed
expression. (A) Three separate RAREs (Khanna et al., 2006) were mutated by sitedirected mutagenesis in the pNrl(1.1 kb)-DsRed backbone. Note that only the 5’ half of
RARE #1 was mutated, in order to avoid disruption of the endogenous splice donor site
within the first intron. (B) The constructs were co-electroporated with pNrl(3.2 kb)-GFP
into retinal explants, cultured for eight days, and imaged in flat-mount. Mutation of
RARE #1 resulted in a slight increase in DsRed expression, while mutation of RARE #2
and RARE #3 caused slight decrements in DsRed expression. (C) Quantification of
dsRed fluorescence of the constructs shown in parts (A) and (B), normalized to wild-type
pNrl(1.1 kb)-DsRed. Error bars, s.d.
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Construct no.

Sequence of site-directed mutagenesis sense primer
(mutated nucleotides underlined), 5’ to 3’

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

TTAACTTCTGGAGTTTCGGGGCGACACGCACCTATTTAAACAGC
GAGTTTCTTTTATCACATACAAGCGGGAAACAGCTTCAGGCAGG
TATCACAGCACCTATTTCCCACTAGGAAGGCAGGTTTAAACATC
CCTATTTAAACAGCTTCCTTACTTGGGAAACATCTCCTTGGCTA
CAGCTTCAGGCAGGTTTCCCACGAGAATTGGCTAAGTCCTACTA
CAGGTTTAAACATCTCCGGTTAGCCTGCCTACTATCCCTGCTTC
CATCTCCTTGGCTAAGTAAGCAGCGAACTGCTTCGGCCCCTACT
GCTAAGTCCTACTATCCAGTAGGGCCGCCCTACTAGGGGGTGAC
ACTATCCCTGCTTCGGCAAAGCAGCTTGGGTGACAGCTCTAAGA
CTTCGGCCCCTACTAGGTTTGTCACTATCTAAGAGGCGTTAGGC
TACTAGGGGGTGACAGCGAGCCTCTTAGTTAGGCGATTAGGCTG
TGACAGCTCTAAGAGGCTGGTCCGTCGTAGGCTGAAAATGTAGG
AAGAGGCGTTAGGCGATGCTTAGTCCCATGTAGGTCACACCCCA
AGGCGATTAGGCTGAAACGTGCTTGACCACCCCAGCCGTCTGGG
GCTGAAAATGTAGGTCAACAAAACTAAGTCTGGGAATGAGCGAG
TAGGTCACACCCCAGCCTGAGTTTCCGGAGCGAGAGAGGAGAAG

Table 2.1: Site-directed mutagenesis primers.
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CHAPTER 3

Partial reprogramming of adult mouse rods into
cones rescues retinal degeneration
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3.1

Introduction

Heritable retinal degeneration is a common cause of visual impairment and blindness,
affecting millions of people worldwide (Sohocki et al., 2001). Many research groups
have focused on targeted gene therapy as a treatment for this disease (Liu et al., 2011),
with success in both animal models and human patients (Ali et al., 2000; Beltran et al.,
2012; Cideciyan et al., 2009). However, retinal disease can be caused by mutations in
any one of more than 200 genes (Daiger, 1998), and the pathogenic mechanisms of
various mutations vary greatly (Montana and Corbo, 2008). Thus, there is a strong
motivation to develop gene-independent therapies that would be more widely applicable
(Farrar et al., 2002; Montana and Corbo, 2008).
Retinitis pigmentosa is a one subtype of retinal degeneration that might be
particularly amenable to a gene-independent approach. Here, mutations in rod-enriched
genes initiate a progressive sequence of rod cell death followed by cone loss (Hartong et
al., 2006). Cone dysfunction is particularly debilitating for patients, yet it appears to be
entirely secondary to rod death: studies in animal models suggest that collapse of the
ONL during rod degeneration may generate an oxidative, nutrient-deficient environment
that is toxic to cones (Komeima et al., 2006; Punzo et al., 2009; Punzo et al., 2012; Shen
et al., 2005; Usui et al., 2009). In this case, preservation of rod cell bodies may be
sufficient to forestall cone death.
In this study, we hypothesized that converting adult rods into cones could make
the cells resistant to the effects of mutations in rod-specific genes, thereby preventing
ONL collapse and secondary cone loss (Fig. 3.1A). Direct, in vivo conversion of one
differentiated cell type into another has been successful in numerous contexts, as
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investigators have converted pancreatic exocrine cells into β-cells (Zhou et al., 2008),
auditory endothelial cells into hair cells (Izumikawa et al., 2005), and fibroblasts into
cardiomyocytes (Qian et al., 2012). To transform rod photoreceptors into cones, we took
advantage of the observation that the photoreceptor transcription factor Nrl acts as a cell
fate switch during development: photoreceptor precursors that turn on Nrl become rods
while those that do not become cones (Daniele et al., 2005; Mears et al., 2001). In this
study, we found that acute inactivation of Nrl in adult mouse rods caused partial
reprogramming to the cone phenotype based on molecular, histologic, and functional
criteria. Moreover, reprogramming of adult rods achieved cellular and functional rescue
of retinal degeneration in a mouse model of retinitis pigmentosa. These findings suggest
that elimination of Nrl in adult rods may represent a novel therapy for retinal
degeneration.

3.2

Germline Nrl knockout suppresses retinal degeneration in the rd1 mouse

For an initial proof-of-principle experiment, we hypothesized that developmental
reprogramming of rod precursors to cones, via germline Nrl knockout, would protect
photoreceptors from the deleterious effects of a mutation in a rod-specific gene. To test
this hypothesis, we created mice with mutations in both Nrl and Pde6b. Pde6b encodes a
subunit of phosphodiesterase, a key component of the rod phototransduction cascade
(Ionita and Pittler, 2007), and Pde6brd1/rd1 mice experience rapid degeneration of nearly
all rods by the end of the second postnatal week (Carter-Dawson et al., 1978; SanchoPelluz et al., 2008) (Fig. 3.1B).

Knockout of Nrl in the Pde6brd1/rd1 background
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completely suppressed the degeneration phenotype (Fig. 3.1B), demonstrating that
developmentally reprogrammed rods are resistant to degeneration.

3.3

Generation and characterization of a conditional Nrl knockout mouse

To determine whether acute Nrl loss is sufficient to abrogate retinal degeneration during
adulthood, we next engineered a floxed allele of Nrl to enable conditional inactivation in
the adult mouse (Fig. 3.2A). The insertion of loxP sites at the Nrl locus did not affect
normal retinal development or function, as assessed by H&E histology (Fig. 3.2B), in situ
hybridization for rod and cone genes (Fig. 3.2B), Nrl and rhodospin protein expression
(Fig. 3.3A-B), and electroretinogram (ERG) analysis (Fig. 3.4A-B).
We next sought to demonstrate that germline knockout of the floxed Nrl allele
recapitulates the all-cone phenotype of the previously published straight Nrl knockout
(Mears et al., 2001). Crossing the Nrl floxed mouse to the Sox2-Cre transgenic line
elicited transmissible, germline recombination of Nrl (Hayashi et al., 2002).

Nrl

knockout mice generated in this fashion, termed NrlCKO/CKO, lacked detectable Nrl protein
(Fig. 3.3B).

There was a total loss of rod-specific genes including Rho, and a

corresponding derepression of cone genes (Fig. 3.2). In addition, ERGs demonstrated
loss of rod function, and a corresponding gain of cone function consistent with functional
conversion of rods into cones, as previously reported for the straight knockout (Daniele et
al., 2005) (Fig. 3.4C-D).
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3.4

Reprogramming adult mouse rods into cone-like cells via Nrl knockout

To directly test the hypothesis that acute Nrl knockdown in the adult mouse would result
in reprogramming of rod photoreceptors into cones, we crossed the Nrl floxed mouse to a
transgenic line carrying a tamoxifen-inducible Cre recombinase (Hayashi and McMahon,
2002), CAG-CreERTM.

Both experimental (Nrlf/f;CAG-CreERTM) and control mice

(Nrl+/f;CAG-CreERTM) were injected daily with 4-hydroxytamoxifen (4-OHT) from
postnatal day 42 (P42) to 44, to induce acute Nrl inactivation.

The animals were

evaluated three weeks later (Fig. 3.5A), at which point the Nrl transcript and protein
product were essentially undetectable in the experimental retinas (Fig. 3.5B and 3.6).
Antibody staining (Fig. 3.5C) and in situ hybridization (Fig. 3.6) revealed that most rod
genes were downregulated, although some genes such as Rho had residual expression.
Conversely, several cone genes including Gnat2, Gnb3, and Pde6c were derepressed, but
the two cone opsins—Opn1mw and Opn1sw—were unaffected (Fig. 3.5C and 3.6). Next
we performed electron microscopy to assess morphological changes induced by acute Nrl
knockout. In the adult Nrl knockout retina, many rods had larger nuclei, more frequent
juxtanuclear mitochondria and more abundant euchromatin than controls (Fig. 3.7).
Thus, the reprogrammed rods displayed a variety of molecular (Corbo et al., 2007) and
morphological (Carter-Dawson and LaVail, 1979a; Corbo and Cepko, 2005) features of
cones.
To test whether the reprogrammed photoreceptors exhibit cone-like physiology,
we performed two sets of functional studies. First, conventional ERGs revealed that
acute Nrl knockout causes a significant decrease in the retinal response to flashes under
scotopic conditions, implying loss of rod function (Fig. 3.8A-B).
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In contrast, the

reprogrammed retinas exhibited a significantly greater maximal photopic a-wave
response compared to controls, suggesting enhanced cone function (3.8A-B).

The

reduced rod function in acute Nrl knockout retinas could be directly observed by
transretinal recordings of the photoreceptor light response (Fig. 3.9A). Notably, darkadapted reprogrammed rods showed a 35-fold desensitization and more rapid inactivation
of their photoresponse compared with control cells, features reminiscent of cones
(Heikkinen et al., 2008).
Since normal cones, but not rods, can utilize the retinol form of visual
chromophore to regenerate their photopigment after bleaching (Wang and Kefalov,
2009), we next tested whether the reprogrammed rods could utilize 9-cis-retinol (a
commercially available analog of 11-cis-retinol) to regenerate their pigment in a retinal
explant preparation (Kolesnikov and Kefalov, 2012).

Following overnight dark-

adaptation, mouse retinas were harvested and dissected free of the retinal pigment
epithelium (RPE) under infrared illumination. Immediately thereafter, control retinas
generated robust responses to a series of light stimuli while reprogrammed retinas
produced a lower maximum response amplitude (Fig. 3.9B).

However, when the

photopigment was bleached after dissection and the retinas were allowed to re-dark adapt
in the presence of 9-cis-retinol, only reprogrammed retinas were able regenerate pigment
and recover their photoresponse (Fig. 3.9B).

Taken together, these findings are

consistent with cellular and functional reprogramming of rods into cone-like cells in the
adult Nrl knockout.
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3.5

Analysis of potential barriers to complete rod-to-cone reprogramming

Since adult Nrl knockout resulted in an incomplete rod-to-cone transformation, we sought
to elucidate what factors might inhibit the phenotypic reprogramming.

First, we

hypothesized that remodeling of certain rod and cone gene loci might simply require
more time. Even 11 weeks following acute knockout, however, rod and cone gene
expression patterns were not different from the patterns observed 3 weeks post-knockout
(Fig. 3.10A).
Second, we hypothesized that persistence of the rod-specific transcription factor
Nr2e3, even at low levels, might be sufficient to maintain the rod transcriptional program.
Nr2e3 acts downstream of Nrl and is a well-characterized activator of rod genes and
repressor of cone genes, including Opn1sw (Chen et al., 2005; Corbo and Cepko, 2005;
Haider et al., 2009; Peng et al., 2005). To test this hypothesis, we performed acute Nrl
knockout on the Nr2e3rd7/rd7 background, which lacks functional Nr2e3 (Akhmedov et al.,
2000; Chen et al., 2006). Even in the Nr2e3-null context, however, Opn1sw was not
derepressed in the dorsal retina (Fig. 3.10B; note that derepression of Opn1sw in the
ventral retina is normally observed in Nr2e3rd7/rd7 mice and therefore is seen in both
control and experimental animals).
Third, we hypothesized that an epigenetic modification, specifically DNA
methylation, might inhibit complete inactivation of certain rod genes and activation of
certain cone genes. Induced pluripotent stem cells (iPSCs) generated by transcription
factor-based reprogramming have been shown to sustain residual DNA methylation
patterns reflecting their tissue of origin (Kim et al., 2010; Ohi et al., 2011); these patterns
are thought to restrict the lineages available for re-differentiation. To test this hypothesis,
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we examined the retinal CpG methylation pattern at the Rho and Opn1sw loci in four
groups of animals at P63: wild-type (C57BL/6), Nrl-/-, control (one floxed Nrl allele
recombined at P42), and acute Nrl knockout (two floxed Nrl alleles recombined at P42)
(Fig. 3.11A-B). Rho is heavily transcribed in rod but not cone photoreceptors, and the
locus is relatively unmethylated in the rod-enriched wild-type and control retinas
compared to the cone-only Nrl-/- retina (Fig. 3.11A). Importantly, acute Nrl knockout
failed to induce an increase in methylation at the Rho locus. Conversely, Opn1sw is
transcribed only in a subset of mouse cones (including the cones of the Nrl-/- mouse); the
locus is highly methylated in wild-type and control retinas and less methylated in Nrl-/retinas (Fig. 3.11B). Acute Nrl knockout did not result in a decrease in methylation at the
Opn1sw locus. These results indicate that Nrl knockout during adulthood fails to elicit
the same gene methylation patterns as Nrl knockout during embryogenesis, and this
failure may explain the differences in gene expression.
Interestingly, the retinal methylation pattern of Opn1sw is established gradually
during development (Susan Shen, personal communication). At P0 and P4 in both wildtype and Nrl-/- retinas, Opn1sw is heavily methylated. Whereas this methylation level is
maintained in wild-type retinas, it is steadily lost in Nrl-/- retinas from P7 through P14 (S.
Shen). Therefore, we hypothesized that the progressive establishment of the Opn1sw
methylation pattern correlates with the progressive loss of responsiveness of the Opn1sw
locus to acute Nrl knockout. To test this hypothesis, we injected mice with 4-OHT at
developmental timepoints to induce Nrl knockout, then assessed Opn1sw expression
three weeks later via in situ hybridization (Fig. 3.12). Consistent with our hypothesis,
acute Nrl knockout at P0 and P4 elicited derepression of Opn1sw, while knockout at later
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timepoints did not. Thus, acute Nrl knockout at the adult stage results in a partial
conversion of mouse rods into cones, and the incompleteness of reprogramming may be
attributable to persistent DNA methylation patterns at certain photoreceptor gene loci.

3.6

Rescue of retinal degeneration in the Rhodopsin null mouse via rod
reprogramming

The Rho-/- mouse is a well-established model of retinitis pigmentosa wherein an initial
period of rod death is followed by secondary cone dysfunction and loss (Jaissle et al.,
2001; Lem et al., 1999) (Fig. 3.13A). To test the hypothesis that conversion of diseased
rods into cones, though incomplete, might achieve rescue of retinal degeneration, we
performed acute Nrl knockout on the Rho-/- background. We induced acute Nrl knockout
by injecting Rho-/- mice with 4-OHT between P25 and P28, before the onset of the major
rod death period (Lem et al., 1999). Evaluation of rescue was performed at P90, a
timepoint when rod death is nearly complete and cone dysfunction is advanced (Jaissle et
al., 2001; Lem et al., 1999) (Fig. 3.13A).
We found that acute Nrl knockout does indeed prevent photoreceptor cell death,
with striking preservation of rod cell bodies (Fig. 3.13B-C). The reprogrammed Rho-/retinas exhibited a gene expression pattern identical to that of reprogrammed wild-type
retinas (Fig. 3.14), and cone opsin expression was well preserved (Fig. 3.13 and 3.14).
Electron microscopy revealed longer photoreceptor inner segments in reprogrammed
retinas relative to controls, although outer segments were not readily apparent (Fig. 3.15).
Most importantly, the histologic and molecular rescue was accompanied by robust rescue
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of cone function, as ERG analysis revealed an intact photopic b-wave over a wide range
of flash intensities (Fig. 3.16A-B).

3.7

Reprogramming and rescue via AAV-delivered Nrl RNAi

To serve as a practical therapy for retinitis pigmentosa in humans, Nrl knockdown must
be deliverable to the retina via viral transduction or other similar means. We therefore
created an adeno-associated virus (AAV) containing an shRNA construct targeting Nrl
('Nrl RNAi') as well as a CAG-GFP cassette to trace the infection. The pseudotyped
AAV-2/5 vector was chosen because of its strong photoreceptor tropism; the onset of
transgene expression is approximately two weeks following subretinal delivery (Allocca
et al., 2007; Auricchio et al., 2001). The Nrl RNAi construct, driven by the U6 promoter,
was previously published and shown to cause efficient Nrl knockdown and
downregulation of Nrl target genes such as Rho (Matsuda and Cepko, 2004).
To test whether Nrl knockdown could recapitulate the gene expression changes
induced by acute genetic ablation, the AAV-Nrl RNAi-CAG-GFP virus was injected into
the subretinal space of P22 C57BL/6 mice. The retinas were harvested three weeks later
and in situ hybridizations were performed for rod and cone genes. Infected areas showed
downregulation of rod genes and derepression of certain cone genes (Fig. 3.17), as
observed with genetic Nrl knockout. However, expression of both cone opsins (Opn1mw
and Opn1sw) was markedly reduced. The cause of cone opsin loss is unknown, although
one group has reported AAV-related cone toxicity that may be attributable to GFP
overexpression (Beltran et al., 2010).

68

Rho-/- mice were then injected subretinally with AAV-Nrl RNAi-CAG-GFP
between P20-22, and the retinas were evaluated at P90. Retinal patches infected with the
virus showed significant preservation of rods compared to both uninfected areas and
patches infected with a scrambled RNAi-containing control virus (Fig. 3.18A-C).
Although functional cone preservation was not achieved in this experiment (data not
shown), the significant cellular rescue suggests that viral-delivered Nrl RNAi has
therapeutic potential.

3.8

Discussion

In this study, we have shown that acute knockdown of Nrl in the adult mouse retina
causes partial reprogramming of rod photoreceptors into cones. The reprogrammed rods
exhibit certain molecular, morphological, and functional characteristics of cones, with
notable exceptions including the lack of Opn1sw derepression and the relatively normal
photopic ERG. Nevertheless, partial conversion of rod photoreceptors was sufficient to
prevent photoreceptor cell death in the Rho-/- model of retinitis pigmentosa.
While the role of Nrl in rod photoreceptor development has been well
characterized (Akimoto et al., 2006; Daniele et al., 2005; Mears et al., 2001; Oh et al.,
2007), this study is the first to elucidate the functional importance of Nrl in the
maintenance of the rod phenotype. We found that Nrl is essential for the transcription of
certain rod genes in adult mice, including Gnat1 and Gnb1.

Other rod genes are

downregulated upon acute Nrl knockout yet not completely absent, including Rho,
Pde6a, Pde6b and Nr2e3. Conversely, certain cone genes like Gnb3, Gnat2, and Pde6c
are derepressed upon acute Nrl ablation, while others like Opn1sw remain unchanged
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(Fig. 3.6). Thus, photoreceptor genes exhibit differing degrees of ‘responsiveness’ to Nrl
knockout at the adult stage.
What factors might account for this variability? First, Nrl may help establish
epigenetic modifications at particular loci during photoreceptor differentiation, and these
modifications may later preserve locus activation or repression independently of Nrl. We
have shown here that the DNA methylation patterns at two refractory loci, Rho and
Opn1sw, remain unchanged following acute Nrl knockout (Fig. 3.11).

Since DNA

methylation is highly correlated with transcriptional activity (reviewed in Deaton and
Bird, 2011), this may explain why Rho and Opn1sw transcript levels remain relatively
unchanged. In this study, we attempted to induce Opn1sw derepression via simultaneous
Nrl knockdown and AID overexpression. AID (activation-induced cytidine deaminase)
is an enzyme that has been shown to participate in active DNA demethylation (reviewed
in Fritz and Papavasiliou, 2010). Delivery of AID via subretinal AAV injection did not
induce Opn1sw derepression (data not shown), and it is currently unclear whether AID
failed to induce demethylation at Opn1sw or whether demethylation was simply
inadequate to trigger Opn1sw expression. In addition to DNA methylation, histone
modifications may also participate in the maintenance of gene expression or silencing
following differentiation. Further studies will be required to elucidate the role of both
activating and silencing histone modifications on the Nrl-independent maintenance of
photoreceptor gene expression.
Second, it is possible that Nrl may activate an unknown transcription factor ‘X’
during development. ‘X’ may then activate a subset of rod genes (for example, Rho but
not Gnat1) and repress a subset of cone genes (Opn1sw but not Gnb3). If expression of
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‘X’ becomes independent of Nrl during adulthood, via autoregulation for instance, then
‘X’ may maintain its regulatory function even following acute Nrl knockout. During this
study, we identified the rod-specific transcription factor Nr2e3 as a potential candidate
for ‘X’. However, acute Nrl knockout on the Nr2e3-null background failed to elicit
derepression of Opn1sw (Fig. 3.10B). Thus, another unknown transcription factor or
factors downstream of Nrl may inhibit complete rod-to-cone transdifferentiation at the
molecular level.
Third, acute Nrl knockout may fail to activate cone transcription factors required
for the expression of genes such as the cone opsins. Activation of these factors may
depend on environmental cues present during development but not adulthood. TRβ2, for
example, has been shown to promote M-opsin expression at the expense of S-opsin (Ng
et al., 2001) in the presence of the thyroid hormone T3 (Applebury et al., 2007). Sall3, in
contrast, appears to activate expression of S-opsin during retinal development (de Melo et
al., 2011). In adult mouse retinas, we attempted unsuccessfully to induce (a) ectopic Mopsin expression via simultaneous Nrl knockdown and TRβ2 overexpression, and (b)
ectopic S-opsin expression via simultaneous Nrl knockdown and Sall3 overexpression
(data not shown). The failure of simple transcription factor overexpression to activate
cone opsin may attest to the complexity of M- and S-opsin regulation during
development. This regulatory pathway involves numerous other transcription factors
including RORα (Fujieda et al., 2009), RORβ (Srinivas et al., 2006), and RXRγ (Roberts
et al., 2005), and post-translational modifications of these factors may also play important
roles (Onishi et al., 2010).
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One interesting feature of the reprogrammed retinas is that the rod transducin αsubunit (Gnat1) appeared to be completely gone at both the transcript and protein level
(Fig. 3.5C and 3.6), yet the retinas still generated a modest scotopic ERG signal (Fig.
3.8).

Gnat1 mutant mice, in contrast, completely lack a rod-driven photoresponse

(Calvert et al., 2000). This prompts speculation that derepressed cone transducin αsubunit (Gnat2) may be substituting for the rod subunit in reprogrammed rod
photoreceptors. Indeed, a previous study demonstrated that the rod and cone transducin
α-subunits are functionally interchangeable in photoreceptors, with comparable signaling
properties (Deng et al., 2009). Expression levels of the other transducin subunits (β and
γ) were not as dramatically altered as the α-subunit according to microarray data (not
shown), so it would be interesting to determine whether the cone α-subunit might be
associating with the rod β and γ subunits in reprogrammed rod photoreceptors.
Despite the incompleteness of rod-to-cone reprogramming, an interesting
consequence of acute Nrl knockout was the gain of cone-like physiological properties.
Two of these features, the reduced scotopic ERG (Fig. 3.8) and 35-fold desensitization
during isolated transretinal recording (Fig. 3.9A), are likely due to a substantial decrease
in the expression of rod-specific phototransduction components including rhodopsin, rod
transducin, and rod phosphodiesterase.

Additionally, isolated reprogrammed retinas

exhibited faster inactivation of the photoresponse (Fig. 3.9A). Fast inactivation is a
hallmark of cone phototransduction (Tachibanaki et al., 2001), and Nrl-/- cones exhibit
this property as well (Daniele et al., 2005; Nikonov et al., 2005). In some species
including carp and zebrafish, faster inactivation of phototransduction in cones relative to
rods is achieved via a highly efficient, cone-specific opsin kinase, GRK7 (Tachibanaki et
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al., 2005; Wada et al., 2006). Since mice express only a single opsin kinase in both rods
and cones (GRK1; Weiss et al., 2001), the inactivation kinetics must also be modulated
by other unknown factors (Nikonov et al., 2005). These factors appear to be functional in
both Nrl-/- cones and rods reprogrammed by acute Nrl knockout.
Another important gain-of-function phenotype in reprogrammed rods is their
ability to utilize an 11-cis retinol analog to regenerate their visual pigment. This capacity
is normally a feature of cones and not rods. The ability of cones to convert 11-cis retinol
into 11-cis retinal makes it possible for them to access the visual cycle in which Müller
glia convert all-trans retinol into 11-cis retinol via a series of enzymatic reactions, as
demonstrated in the salamander, mouse, primate, and human (Wang et al., 2009; Wang
and Kefalov, 2009). The fact that reprogrammed rods are able to regenerate pigment and
dark-adapt by utilizing 9-cis retinol (an analog of 11-cis retinol) (Fig. 3.9B) implies that
acute Nrl knockout induces expression of a factor, possibly a dehydrogenase, that can
mediate conversion of 11-cis retinol (or 9-cis retinol) to the retinal form.

Further

experiments would be required to determine the identity of this enzyme.
Apart from providing some insights into the plasticity and maintenance of
photoreceptor

identity,

this

study

has

demonstrated

that

partial

rod-to-cone

reprogramming can forestall retinal degeneration in the Rho-/- model of retinitis
pigmentosa (Fig. 3.13 and 3.18).

At this time, we are unsure of the mechanism

underlying the preservation of reprogrammed rod photoreceptors. These cells are not
true cones, yet they may exhibit sufficient downregulation of rod-specific genes to
become immune from the deleterious effects of mutations in these genes. Interestingly,
the rod gene expression changes induced by acute Nrl knockout are similar to those
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observed following treatment of the retina with ciliary neurotrophic factor, or CNTF
(Wen et al., 2006). This suggests that these two manipulations, acute Nrl knockout and
CNTF delivery, may preserve rod photoreceptors via a related pathway.

The

neuroprotective mechanism of CNTF is unclear, but one hypothesis is that
downregulation of the rod phototransduction machinery reduces the metabolic stress on
cells prone to degeneration (reviewed in Wen et al., 2012). It will be necessary to test
acute Nrl knockout in other models of retinitis pigmentosa, including models of
autosomal dominant disease (Price et al., 2011), to determine whether it is a truly
universal therapy for retinal degeneration caused by mutations in rod-specific genes.

3.9

Materials and methods

Animals
The following mouse strains were maintained on a 12-h light-dark schedule at 20-22oC,
with free access to food and water: Nrl-/- (Mears et al., 2001), Rho-/- (Lem et al., 1999),
C57BL/6 (Taconic, Hudson, New York), Sox2-Cre (Jackson Laboratories, Bar Harbor,
Maine), Pde6brd1 (Jackson Laboratories), CAG-CreERTM (Hayashi and McMahon, 2002),
Nrl floxed, and Nrl CKO. All experiments were conducted in accordance with the Guide
for the Care and Use of Laboratory Animals and the Animal Welfare Act and were
approved by the Washington University in St. Louis Institutional Care and Use
Committee (approval no. 20110089).
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To generate the Nrl floxed mouse, a targeting vector was constructed using
recombineering methods (Lee et al., 2001). Briefly, a genomic region encompassing 9.1
kb of the Nrl locus was subcloned from BAC RP23-90H9 (CHORI, Oakland, California)
into a modified pBluescript vector. A loxP site was inserted 240 bp downstream of Nrl
exon 3, and a loxP-flanked neo cassette was inserted 122 bp downstream of exon 2. The
construct was linearized with NotI prior to transfection into SCC10 embryonic stem (ES)
cells. Successful transformants were confirmed by Southern blotting and karyotyped.
The floxed neo cassette was then removed by transient transfection with Cre
recombinase, and ES cells were injected into C57BL/6 blastocysts for chimera
production. Genotyping primers for the Nrl floxed allele are listed in Table 3.1.
To generate the Nrl CKO mouse, the Nrl floxed line was crossed to the deleter
strain Sox2-Cre (Hayashi et al., 2002). Genotyping primers for the recombined Nrl allele
are listed in Table 3.1.
To induce Cre recombinase activity in mice carrying the CAG-CreERTM transgene,
animals were injected intraperitoneally, daily for three consecutive days, with 0.75 mg 4hydroxytamoxifen (4-OHT; Sigma) dissolved in 15% ethanol / 85% corn oil.

The

reprogramming or control phenotypes were confirmed in all animals via in situ
hybridization for Nrl, Gnat1, Gnb3, and Opn1sw.

A number of animals exhibited

spontaneous, tamoxifen-independent induction of Cre recombinase activity during
development, evidenced by patchy derepression of Opn1sw in the ONL of both
tamoxifen- and vehicle-treated Nrlf/f;CreERTM and Rho-/-;Nrlf/f;CreERTM animals; all data
from these animals were discarded.
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Histology and staining
For immunohistochemistry and in situ hybridizations (ISH), retinas were dissected in
PBS and fixed in 4% paraformaldehyde for 30 min at room temperature. Tissue was
equilibrated in 30% sucrose overnight prior to embedding in Tissue-Tek OCT compound
(Sakura, Torrance, California). Frozen blocks were sectioned at a thickness of 12 μm.
For H&E staining, whole eyes were fixed in 4% paraformaldehyde overnight at 4oC.
Eyes were dehydrated to 100% ethanol, embedded in paraffin, and sectioned at a
thickness of 4 μm. H&E staining was performed by standard methods.
For antibody staining, frozen sections were blocked in 5% normal donkey serum /
0.1% triton X-100 for 1 h at room temperature (RT). Sections were incubated in primary
antibody overnight at 4oC. Following PBS rinses, sections were incubated in secondary
antibody (1:800, Alexa Fluor 555 donkey anti-rabbit or donkey anti-mouse; Invitrogen)
for 30 min at RT, DAPI-stained, and coverslipped with Vectashield mounting medium
(Vector Labs, Bulingame, California). Primary antibodies used were a polyclonal antiblue opsin raised in rabbit (1:200, Millipore), a polyclonal anti-red/green opsin raised in
rabbit (1:600, Millipore), a polyclonal anti-rod transducin α-subunit raised in rabbit
(1:1500, Santa Cruz Biotechnology), and a mouse monoclonal anti-rhodopsin antibody
(Rho4D2; 1:600, kind gift from Dr. Cheryl Craft). Confocal image stacks were captured
using a BX61 WI microscope (Olympus) equipped with a DSU spinning disc and an
ORCA-ER CCD camera (Hamamatsu). Image stacks were processed using SlideBook
software (Intelligent Imaging Innovations, Denver, Colorado) and Photoshop CS4
(Adobe).
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ISH was performed on frozen retinal sections as previously described (Chen and
Cepko, 2000).

RNA riboprobes were synthesized from PCR templates previously

described (Corbo et al., 2007) with the exception of probes for Nrl, Nr2e3, Gnat2, and
Pde6c. Templates for the latter probes were generated by PCR from mouse retinal cDNA
using primers listed in Table 3.1.
For electron microscopy, eyecups were fixed by immersion for 12-24 h in 2%
paraformaldehyde, 3% glutaraldehyde in 0.1 M phosphate buffer (pH 7.35), post-fixed in
1% osmium tetroxide for 1 h and stained en bloc with 1% uranyl acetate in 0.1 M acetate
buffer for 1 h. Blocks were then dehydrated in a graded series of water-based acetone
solutions and embedded in Araldite 6005/Embed 812 resin. Semi-thin sections (0.5-1
μm) were cut through the entire retina at the level of the optic nerve. Ultra-thin sections
were taken from the first 600-800 μm of tissue adjacent to the optic nerve, post-stained
with uranyl acetate and lead citrate, and viewed on a Hitachi H7500 electron microscope.
Image montages were generated using Photoshop CS4.

Quantification of ONL cells
H&E-stained paraffin sections (Rho-/-;Nrlflox;CreERT) or DAPI-stained frozen sections
(AAV-treated Rho-/-) were imaged at 400X magnification and cropped to a retinal length
of 300 μm. Cell bodies in the ONL were counted using ImageJ software (Rasband, 1997)
and the Cell Counter plugin (Kurt de Vos, University of Sheffield).

For Rho-/-

;Nrlflox;CreERT animals, two central fields per animal were counted and averaged. For
AAV-treated Rho-/- animals, one GFP(+) and one GFP(-) field per animal were counted.
Statistical analysis was performed using GraphPad Prism 5 software.
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Western blot analysis
One retina from each animal was dissected and immersed in 200 μl of modified RIPA
buffer (65 mM Tris base, 154 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium
deoxycholate, 1 mM PMSF, 1% protease inhibitor Sigma P8340, 1% phosphatase
inhibitor Sigma P2850; pH 7.4). Tissue was lysed via sonication and centrifuged at 4oC.
Protein in the supernatant was quantified using the BCA Protein Assay Kit (Thermo
Fisher Scientific). An equal amount of protein from each sample was loaded on a 10%
Bis-Tris SDS-PAGE gel (Invitrogen), separated by electrophoresis, and transferred to a
nitrocellulose membrane (Whatman). Membranes were blocked for 1 h at RT in the
following solutions: for the rhodopsin antibody, 5% nonfat dry milk in 1X TBST (150
mM NaCl, 10 mM Tris pH 8.0, 0.1% Tween-20); for the Nrl antibody, 5% normal
donkey serum in 1X TBST.

Membranes were incubated in the following primary

antibodies overnight at 4oC:

mouse monoclonal anti-rhodopsin antibody Rho4D2

(1:10,000; kind gift from Dr. Cheryl Craft) or goat polyclonal anti-Nrl antibody (1:500;
R&D Biosystems, Minneapolis, Minnesota).

Secondary antibody incubation was

performed for 1 h at RT in horseradish peroxidase (HRP)-conjugated goat anti-mouse
(1:10,000, Thermo Fisher Scientific) or donkey anti-goat (1:5000, Thermo Fisher
Scientific). Membranes were treated with ECL reagent (Thermo Fisher Scientific) per
manufacturer instructions, exposed to x-ray film for detection, and stripped of the
primary antibodies using mild stripping buffer (200 mM glycine, 0.1% SDS, 1% Tween20; pH 2.2). Following 1 h block at RT in 5% BSA / 1X TBST, membranes were reprobed with anti-β-tubulin (1:10,000; Sigma) overnight at 4oC. Membranes were
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incubated in HRP-conjugated goat anti-mouse (1:5000, Thermo Fisher Scientific) for 1 h
at RT and developed as previously stated.

Bisulfite methylation analysis
One retina from each animal was dissected in PBS, and genomic DNA was purified from
minced retinal tissue using the Gentra Puregene kit (Qiagen). Bisulfite conversion of
retinal DNA was performed with the EpiTect Bisulfite Kit (Qiagen). The Rho locus (298 to +202 relative to the transcription start site) and Opn1sw locus (-4 to +473) were
amplified from bisulfite-converted DNA using primers listed in Table 3.1, and the PCR
products were cloned into the pCR4-TOPO vector (Invitrogen) per manufacturer
instructions.

Individual clones were purified and sequenced by Beckman Coulter

Genomics (Danvers, Massachusetts) using the T3 primer.
Clones with >95% bisulfite conversion rate were analyzed using BISMA software
(Rohde et al., 2010) to retrieve the percent methylation of individual CpG’s. Fig. 3.11
was assembled using data generated by BISMA and graphics generated by CpGviewer
(Carr et al., 2007) and Photoshop CS4.
Two biological replicates were processed for each genotype, and each biological
replicate produced 11-24 acceptable sequences.

Electroretinography
ERGs were performed as described in (Kolesnikov et al., 2011) with minor
modifications. For the scotopic ERG, a digital 60-Hz notch filter was used to reduce
noise interference at the three lowest flash intensities. For the photopic ERG, mice were
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light-adapted for 10 min, and test flashes were applied in the presence of dim (29 cd/mm)
background illumination. All test flashes were 10 μs in duration, and 5-10 responses
were averaged per flash intensity. Statistical analysis was performed using GraphPad
Prism 5 software.

Recordings from isolated retinas
Mice were dark-adapted overnight and sacrificed by CO2 asphyxiation and cervical
dislocation. Retinas were removed under infrared illumination and stored in oxygenated
aqueous L15 solution (13.6 mg/ml, pH 7.4, Sigma) containing 0.1% BSA, at RT. Prior to
recording, the retina was mounted on filter paper with the photoreceptor side up and
placed in the recording chamber. One electrode was connected to the bottom of the
perfusion chamber, and a second electrode was placed just above the center of the retina.
The retina was perfused throughout the recording session with Locke’s solution (112.5
mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 10 mM HEPES pH 7.4, 20 mM
NaHCO3, 3 mM Na succinate, 0.5 mM Na glutamate, 0.02 mM EDTA, 10 mM glucose).
The solution was supplemented with 2 mM L-glutamate and 10 µM DL-AP-4 to block
higher order components of the photoresponse (Sillman et al., 1969a, b), with 20 µM
BaCl2 to suppress the glial component (Nymark et al., 2005), and with MEM vitamins
and MEM amino acid solutions (Sigma) to improve retina viability. The perfusion
solution was bubbled continuously with 95% O2 / 5% CO2 mixture and heated to 36–
37°C. The electrode solution (140 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM
CaCl2, 3 mM HEPES, 10 mM glucose; pH 7.4) in the lower electrode space also
contained 2 mM L-glutamate and 10 mM BaCl2.
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Near-complete bleaching of the visual pigment was performed on a filter papermounted retina placed in a small Petri dish. The retina was exposed for 2 min to a 100 W
halogen bulb light source coupled to a 520 nm interference filter. The retina was then
allowed to dark-adapt for 2.5 h at RT, in L15 solution with or without 9-cis-retinol (final
concentration 130 µM, with 0.1% ethanol and 1% BSA added), in a dark box saturated
with pure oxygen. Following dark adaptation the retina was placed in the recording
chamber as described above.
Light stimulation was applied by 20 ms test flashes of calibrated 505-nm LED
light. For light uniformity, a glass optical diffuser was placed between the LED and the
retina. The stimulating light intensity was controlled by neutral density filters and a
computer in 0.5 log unit steps. Photoresponses were amplified by a differential amplifier
(DP-311; Warner Instruments), low-pass filtered at 30 Hz (8-pole Bessel), digitized at 1
kHz and stored on a computer for further analysis. Half-saturating light intensity (I1/2)
was calculated from the intensity-response relation for each retina as the test flash
intensity required to produce a response with an amplitude equal to half of the
corresponding saturated response amplitude. Integration time (Tintegr.) was calculated as
the integral of the dim flash response with the transient peak amplitude normalized to
unity. The time constant of the dim flash response recovery (τrec) was derived from
single-exponential fit to the falling phase of the response. Data were analyzed using
Clampfit 10.2 and Origin 8.5 software.
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Construction of AAV vectors
The Nrl RNAi expression construct pBSU6-Nrl RNAi has been previously described
(Matsuda and Cepko, 2004).

To create the scrambled RNAi expression construct,

pBSU6-Scrambled RNAi, the nucleotides of the Nrl RNAi targeting arm were
randomized and screened with BLAST (NCBI) to confirm that the new sequence did not
target any known mouse genes. Oligonucleotides encoding an shRNA construct with the
scrambled sequence (Table 3.1) were annealed and inserted into the pBS/U6 vector (Sui
et al., 2002) digested with ApaI (blunted) and EcoRI.
pBSU6-Nrl RNAi or pBSU6-Scrambled RNAi, digested with PvuII and KpnI,
was inserted into the AAV-2 expression vector pTR-UF11 (kind gift from Dr. William
Hauswirth), digested with SalI (blunted) and KpnI, to create AAV-RNAi. CAG-GFP
(Matsuda and Cepko, 2004) was then digested with ApaLI (blunted) and HindIII
(blunted) and inserted into AAV-RNAi, digested with SalI (blunted), to create AAV-Nrl
RNAi-CAG-GFP or AAV-Scrambled RNAi-CAG-GFP.
AAV-Nrl

RNAi-CAG-GFP

and

AAV-Scrambled RNAi-CAG-GFP were

packaged into the AAV-5 viral capsid by the Hope Center Viral Core (Washington
University School of Medicine) to generate an AAV-2/5 virus.

Viral titers were

measured by dot blot.

Subretinal injections
Mice were anesthetized with a subcutaneous injection of ketamine (80 mg/kg) / xylazine
(20 mg/kg), and proparacaine ophthalmic solution (Falcon Pharmaceuticals, Fort Worth,
Texas) was applied to the cornea. Under a dissecting microscope at low power, the
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mouse eye was gently proptosed and a sterile 30G needle was used to puncture the sclera
just beneath the corneal margin. A Hamilton syringe with blunt-tipped 32G needle,
containing 1 μl AAV-Nrl RNAi-CAG-GFP (2.6 x 1012 vg/ml) or AAV-scrambled RNAiCAG-GFP (1.2 x 1012 vg/ml), was inserted through the hole and advanced through the
vitreous chamber until the needle was in the subretinal space. The viral solution was then
injected. Following injection, Vetropolycin ointment (Pharmaderm, Melville, New York)
was applied to the cornea. Typically, one eye was injected with AAV-Nrl RNAi-CAGGFP and the other eye was injected with AAV-Scrambled RNAi-CAG-GFP.
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Figure 3.1: Rod reprogramming therapy. (A) Hypothesis that the normal progression
of photoreceptor degeneration in retinitis pigmentosa might be circumvented by
reprogramming of rods into cones via acute Nrl knockout. (B) Mice homozygous for the
mutant rd1 allele of rod-specific Pde6b have lost nearly all rod photoreceptors by P36.
Germline deletion of Nrl on the Pde6brd1/rd1 background suppresses the degeneration
phenotype. ONL, outer nuclear layer; INL, inner nuclear layer; GCL, ganglion cell layer.
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Figure 3.2: Engineering a conditional allele of Nrl. (A) Schematic of the conditional
Nrl allele; the first coding exon (ex3) is flanked by loxP sites. (B) Nrlf/f retinas are
indistinguishable from wild-type retinas by H&E histology and staining for a variety of
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rod and cone transcripts at P63. A straight Nrl knockout mouse, NrlCKO/CKO, was created
by crossing the Nrl floxed mouse to the Sox2-Cre transgenic line which causes germline
recombination (Hayashi et al., 2002). Photoreceptor gene expression patterns in the
NrlCKO/CKO and canonical Nrl-/- mice (Mears et al., 2001) are identical.
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Figure 3.3: Nrl and rhodopsin protein expression in Nrlf/f and NrlCKO/CKO retinas.
(A) Rhodopsin protein is present in the outer segments of Nrlf/f but not NrlCKO/CKO retinas
at P63. (B) Western blot of protein isolated from whole retinas reveals similar levels of
Nrl and rhodopsin in Nrl+/+ and Nrlf/f retinas. NrlCKO/CKO retinas, in contrast, lack both
Nrl and rhodopsin protein. β-tubulin, loading control.
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Figure 3.4: Electroretinogram analysis of Nrlf/f and NrlCKO/CKO mice. (A)-(B) ERGs
recorded from Nrl+/+ and Nrlf/f mice at P63 revealed no significant differences in
photoresponsiveness at any flash intensity under scotopic and photopic conditions (n = 7
mice per genotype). (C)-(D) ERGs recorded from Nrl+/CKO (n = 5) and NrlCKO/CKO (n = 6)
mice at P63 revealed a significant decrease in the NrlCKO/CKO response to flashes under
scotopic conditions, implying loss of rod function. Under photopic conditions, however,
the NrlCKO/CKO retinas exhibited a larger response to flashes than the controls, consistent
with increased cone function as previously reported for the Nrl-/- mouse (Mears et al.,
2001). P values for 2-way ANOVA: *P<0.05, **P<0.01, ***P<0.001. Error bars, s.e.m.
88

Figure 3.5:

Acute Nrl knockout in adult mice.

knockout experiments presented in this figure.

(A) Timeline for the acute Nrl
Animals were injected with 4-

hydroxytamoxifen (4-OHT) daily for three days starting at P42, to induce CreERTM
activity. Phenotypes were evalued three weeks later at P63. Unless otherwise specified,
control is Nrl+/f;CreERTM + 4-OHT and acute Nrl knockout is Nrlf/f;CreERTM + 4-OHT. (B)
Three weeks following acute Nrl knockout, Nrl protein is nearly gone from whole retinal
extracts, while rhodopsin protein is decreased. β-tubulin, loading control. (C) The ONL
remains intact following acute Nrl knockout, albeit with a variably wavy appearance. By
antibody staining for outer segment proteins, rod transducin (alpha subunit, encoded by
Gnat1) is drastically reduced while other proteins as not as affected.
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Figure 3.6: Acute Nrl knockout induces changes in the expression pattern of specific
photoreceptor genes. Three weeks following acute Nrl knockout, in situ hybridization
reveals downregulation of numerous rod-specific transcripts, although low expression
levels persist for certain genes such as Rho. Conversely, a number of cone genes (Gnat2,
Gnb3, and Pde6c) were derepressed. Notably, however, the Opn1sw expression pattern
remained unchanged following acute Nrl knockout.
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Figure 3.7:

Electron microscopy reveals cone-like morphological features of

reprogrammed rod nuclei. Compared to photoreceptor nuclei in the control animal
(Nrlf/f;CreERTM + vehicle), reprogrammed photoreceptor nuclei (Nrlf/f;CreERTM + 4-OHT)
are larger, contain more abundant euchromatin, and possess more frequent juxtanuclear
mitochondria, which are morphological features reminiscent of cones. Scale bars, 2 μm.
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Figure 3.8: Electroretinogram analysis of animals subjected to acute Nrl knockout.
(A) Acute Nrl knockout mice (n = 8) had significantly lower a-wave and b-wave
amplitudes under scotopic conditions than control mice (n = 10). The photopic response
was mostly unchanged except for a significantly higher a-wave response to the highest
flash intensity in acute Nrl knockout mice relative to controls. P values for 2-way
ANOVA: **P<0.01, ***P<0.001.

Error bars, s.e.m.

waveforms.
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(B) Representative ERG

Figure 3.9: Transretinal recordings of control and acute Nrl knockout retinas. (A)
Families of responses to increasing light intensities for dark-adapted, isolated control and
acute Nrl knockout retinas. Red trace, photoresponses to a light intensity of 392 photons
μm-2 (505 nm). (B) Responses to 505 nm test-flashes recorded from isolated retinas,
lacking RPE, under various conditions (n ≥ 3 animals per condition). Bleach, exposed to
520 nm light for 2 min followed by dark-adaptation for 2.5 h.; 9-cis-ROL, the 2.5 h darkadaptation was conducted in the presence of 130 µM 9-cis-retinol. Data were fitted with
the Naka-Rushton hyperbolic function. Error bars, s.e.m.
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Figure 3.10:

Time and residual Nr2e3 expression do not account for the

incompleteness of rod-to-cone transdifferentiation.

(A) Control and acute Nrl

knockout retinas were evaluated via in situ hybridization 11 weeks following Cre
induction, and Opn1sw expression was still unchanged. (B) Acute Nrl knockout was
induced on the rd7 background, which lacks functional Nr2e3.

Opn1sw was not

derepressed in the dorsal retina as it is in the developmental Nrl knockout. Note that
derepression of Opn1sw in the ventral retina is normally observed in the Nr2e3rd7/rd7
mouse.
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Figure 3.11: Epigenetic barriers to reprogramming of rods into cones. Retinal DNA
methylation status of the Rho (A) and Opn1sw (B) loci for four genotypes, C57BL/6
(wild-type), Nrl-/-, control (Nrl+/f;CreERT2 + 4-OHT) and acute Nrl knockout
(Nrlf/f;CreERT2 + 4-OHT).

Each circle represents a single CpG; shading indicates

percentage methylation across ≥ 28 clones (from two biological replicates). Graph at
right represents overall locus methylation; error bars, s.d.

Phastcons, vertebrate

phylogenetic conservation track from UCSC Genome Browser (Rhead et al., 2010).
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Figure 3.12:

The Opn1sw locus gradually becomes refractory to Nrl knockout

during development. Mice were injected with 4-OHT to induce Nrl knockout at various
developmental timepoints, and the Opn1sw transcript was detected three weeks later by
in situ hybridization. Nrl knockout at P0 and P4 causes partial derepression of Opn1sw in
the ONL, but knockout at later timepoints fails to elicit Opn1sw derepression. Images
depict the dorsal retina, which has sparse Opn1sw expression in wild-type mice.
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Figure 3.13: Partial reprogramming of rods into cones rescues retinal degeneration.
(A) Timecourse of photoreceptor degeneration in Rho-/- retinas (top) and timeline for
acute Nrl knockout experiments on the Rho-/- background (bottom). Control is Rho-/;Nrl+/f;CreERTM + 4-OHT and acute Nrl knockout is Rho-/-;Nrlf/f;CreERTM + 4-OHT. (B)
H&E and antibody staining show increased preservation of the ONL and cone opsin
expression in Rho-/- animals treated with acute Nrl knockout relative to controls. (C)
Quantification of ONL cells in 300-μm segments of retina (n = 3 animals per genotype).
***P<0.001 by unpaired t-test. Error bars, s.d.
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Figure 3.14: Analysis of photoreceptor
gene expression in Rho-/- animals with
acute genetic ablation of Nrl. Control
(Rho-/-;Nrl+/f;CreERTM)

and

acute

Nrl

knockout animals (Rho-/-;Nrlf/f;CreERTM)
were treated with 4-OHT at P25-28 and
sacrificed at P90.

Gene expression

patterns were evaluated via in situ
hybridization.
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Figure 3.15: Electron micrograph montages of Rho-/- retinas treated with acute Nrl
knockout. Compared to the control, the rescued retina has greater preservation of the
ONL (marked by dashed lines). The photoreceptor inner segments are also longer. Scale
bar, 4 μm.
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Figure 3.16: Rho-/- retinas treated with acute Nrl knockout have preserved cone
function. (A) Photopic ERGs recorded from control (n = 10) and acute Nrl knockout
mice (n = 10) on the Rho-/- background. The b-wave amplitude was significantly greater
in the acute knockout mice relative to controls. P values for 2-way ANOVA: **P<0.01,
***P<0.001. Error bars, s.e.m. (B) Representative ERG waveforms.
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Figure 3.17: AAV-delivered Nrl RNAi recapitulates the gene expression changes
induced by acute Nrl knockout. Wild-type (C57BL/6) mice were injected subretinally
at P22 with an adeno-associated virus delivering Nrl RNAi and GFP, AAV-Nrl RNAiCAG-GFP. Animals were sacrificed at P43 and retinal gene expression changes were
analyzed by in situ hybridization.
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Figure 3.18: AAV-delivered Nrl RNAi rescues photoreceptor cell bodies in Rho-/mice. (A)-(B) Rho-/- mice were injected subretinally with an adeno-associated virus
delivering either a scrambled RNAi control construct (A) or the Nrl RNAi construct (B)
between P20-P22. Mice were sacrificed at P90, and retinal sections were stained with
DAPI to visualize cell bodies. (C) Retinal areas infected with AAV-Nrl RNAi, but not
AAV-Scrambled RNAi, had greater preservation of the ONL compared to non-infected
areas (n ≥ 5 retinas per condition). P values for unpaired t-test: *P<0.05, ***P<0.001.
Error bars, s.d.
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Description

Sequence (5’-3’)

PCR prod.

Nrl flox genotyping, F
Nrl flox genotyping, R
Nrl CKO genotyping, F
Nrl CKO genotyping, R
Nrl ISH probe, F
Nrl ISH probe, R
Nr2e3 ISH probe, F
Nr2e3 ISH probe, R
Gnat2 ISH probe, F
Gnat2 ISH probe, R
Pde6c ISH probe, F
Pde6c ISH probe, R
Rho bisulfite, F
Rho bisulfite, R
Opn1sw bisulfite, F
Opn1sw bisulfite, R
Scrambled RNAi, S

TGGAAGGGCCTCTTGGCTACTATT
AAAGCGATCTAGCCAGGCAGTGAT
ATCCCTGCAGTCTGCCTCTA
CACAGCTCTCCACTCCTTCC
GAATGGCTTTCCCTCCCAGTCCC
GGACATGCTGGGCTCCTGTCTC
ATGAGCTCTACAGTGGCTG
CTAGTTTTTGAACATGTCACACAGG
ATGGGGAGTGGCATCAGTG
TTAAAAGAGCCCACAGTCCTTGAG
TTGTTGCTGTCGCACTAAGG
TGACAGGACGGTACCCTTTC
AGTGAATTTAGGGTTTAAAGGTTTT
CTACCAACATAAAAAACTACCATAATTC
TTAATTGTATTTTTAAAGGAGGGTGTT
CTCTCTCTAACCCAAATTACCTTCA
GTCGGCTCGTCGTAGAATGTGAAGCTTGACATTCTACGACGAGCCGACCTTTTTG
AATTCAAAAAGGTCGGCTCGTCGTAGAATGTCAAGCTTCACATTCTACGACGAGCCGAC

Floxed 475 bp
WT 381 bp
Recombined
allele 341 bp
381 bp

Scrambled RNAi, AS

Table 3.1: Oligonucleotides used in this study.
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1188 bp
1065 bp
1023 bp
500 bp
477 bp
N/A

CHAPTER 4

Summary and future directions
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4.1

Summary

This thesis has elucidated the regulation of the mouse rod photoreceptor determinant Nrl,
as well as the consequences of acute Nrl knockout in the differentiated retina. In this
chapter, I will summarize the major findings, discuss topics for future research, and
propose an experimental assay that might be useful in the continued study of rod-to-cone
reprogramming.

Transcriptional regulation of Nrl
Experiments discussed in Chapter 2 demonstrated that Nrl expression is directly
regulated by the transcription factors Crx, Otx2, and RORβ. These factors bind to
discrete sites within a phylogenetically conserved, 30-base pair region in the Nrl
promoter. Mutation of these sites is sufficient to abolish Nrl promoter activity in mouse
retinal explants electroporated with fluorescent reporter constructs.

Moreover,

quantitative RT-PCR in wild-type and Crx-/- retinas, as well as Otx2 and Crx knockdown
experiments in retinal explants, suggest that Otx2 and Crx coordinately regulate Nrl
during early retinal development. In adult retinas, however, Nrl expression is likely
maintained mostly by Crx and possibly by RORβ.
These results are significant because they establish a direct regulatory connection
between Nrl and known mediators of photoreceptor differentiation. Additionally, the
identification of a critical cis-regulatory region may facilitate the correlation of human
mutations in this region with retinal disease.
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Partial reprogramming of rod photoreceptors into cones
The hypotheses tested in Chapter 3 were based on the observation that Nrl is a
developmental cell fate switch: photoreceptor precursors that turn on Nrl become rods,
while those that do not become cones. First, we hypothesized that acute knockout of Nrl
in adult rod photoreceptors would trigger transdifferentiation into cones. Experiments
performed in a drug-inducible Nrl knockout mouse showed that rod photoreceptors did,
in fact, acquire some cone-like molecular, morphological, and functional features upon
acute Nrl knockout. However, rod-to-cone reprogramming was incomplete, possibly due
to developmentally established epigenetic barriers such as DNA methylation.
Second, we hypothesized that partial reprogramming of rods into cones would
rescue retinal degeneration caused by mutations in rod-enriched genes. Specifically, we
reasoned that converting diseased rods into cone-like cells would prevent primary rod
photoreceptor death, thus circumventing secondary death of endogenous cones. Acute
Nrl knockout in the Rho-/- model of retinitis pigmentosa did indeed prevent rod cell death,
and cone function was preserved. This result is significant because it suggests that acute
Nrl knockdown may represent a novel, widely applicable therapy for a subset of retinal
diseases.

4.2

Future directions

This body of work has clarified certain aspects of Nrl regulation and the plasticity of
photoreceptor identity, but many interesting questions remain.
avenues for future research within the topics addressed by this thesis.
108

Here, I review key

The initiation of Nrl expression in photoreceptor precursors
Despite the identification of Nrl transcriptional regulators by this thesis research and by
other investigators (Kautzmann et al., 2011), the factors that promote initial Nrl
expression specifically in rod photoreceptor precursors remain unknown.

There are

numerous models that could potentially account for the rod-versus-cone fate decision.
For example, dynamic environmental factors during development may predispose laterborn photoreceptor precursors to activate transcription of Nrl.

Alternatively, early

expression of both Nrl and an unknown, antagonistic transcription factor may establish a
bistable state in photoreceptor precursors via mutual inhibition. Slight perturbation of
this state could then induce dominance of one transcription factor over the other, resulting
in commitment to either the rod or cone fate (Zhou and Huang, 2011).
Elucidation of the specific mechanism whereby rod and cone precursors diverge
may require difficult experiments such as transcriptome analysis of retinal progenitor
cells, or identification of Nrl cis-regulatory elements that directly respond to diffusible
factors present in the developing retina.

Prospects for complete rod-to-cone reprogramming and functional implications
Interestingly,

Nrl

deletion

during

adulthood

only

partially

developmental knockout phenotype of rod-to-cone fate switching.
important question:

recapitulated the
This prompts an

is it even possible to induce full conversion of adult rod

photoreceptors into cones at the molecular, morphological, and functional levels?
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Numerous examples of somatic cell reprogramming (discussed in Chapter 1)
engender optimism for complete photoreceptor transdifferentiation under appropriate
experimental conditions. These conditions may need to be determined empirically; in
most cases of successful reprogramming, investigators initially overexpressed large pools
of factors in cells, then gradually narrowed down the pools to those factors essential for
reprogramming (Ieda et al., 2010; Vierbuchen et al., 2010; Zhou et al., 2008). The next
section of this chapter describes an assay that could be used to determine sets of factors
that promote complete reprogramming of rod photoreceptors into cones.
If full rod-to-cone conversion does prove possible, then this system could provide
powerful insights into the functional consequences of a change in cellular identity.
Interestingly, the cone photoreceptors of the Nrl-/- mouse have been shown to synapse on
rod bipolar cells, which then connect normally to AII amacrine cells (Strettoi et al.,
2004).

This suggests that reprogramming of adult mouse rods into cones may not

necessarily be accompanied by synaptic remodeling in the outer plexiform layer.
However, it would be interesting to determine whether rod-to-cone conversion triggers
remodeling of other retinal cell types and their connections, which has been observed
under conditions such as retinal detachment and photoreceptor degeneration (reviewed in
Fisher et al., 2005; Jones and Marc, 2005).
Another important question concerns visual function in animals with
photoreceptor reprogramming: would the animals be able to correctly process visual
information originating from the neo-cones? Electroretinography can detect changes in
retinal currents, such as increased responsiveness to short-wavelength light due to S-cone
gain-of-function (Mears et al., 2001). It may be difficult to evaluate cone gain-of110

function phenotypes using behavioral assays that test higher-order visual processing, such
as the optokinetic reflex and two-alternative, forced-choice visual discrimination task
(Cahill and Nathans, 2008; Prusky et al., 2000). However, the successful integration of
light information from reprogrammed cones would bode well for patients with conedominant retinal disease, such as macular degeneration.

In these patients, the

reprogramming of relatively healthy rods into functional cones may restore daylight and
possibly high-acuity vision, depending on the extent of inner retina remodeling.

4.3

An experimental assay for determining combinations of factors that result in
complete rod-to-cone reprogramming

Since knockdown of a single transcription factor, Nrl, is insufficient to cause complete
rod-to-cone conversion, an assay may be required to identify additional factors required
for full photoreceptor reprogramming. Such an assay must satisfy several criteria to be
effective. First, it should be relatively high-throughput such that multiple conditions
could be tested in a given experiment. Second, it must accommodate the simultaneous
expression of many different factors in individual cells. Third, it should allow for both
transient and constitutive expression of specific factors. For example, initial but not
prolonged expression of X or Y may promote rod-to-cone reprogramming, while factor Z
might require continuous expression for the maintenance of cone identity. Lastly, the
assay must have a clear readout for reprogramming success or failure.
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Experimental outline
Here, I propose an in vivo electroporation assay that satisfies these requirements (Fig.
4.1). This assay utilizes two different protein expression methods: the doxycyclineinducible Tet-On 3G® system (Clontech) for transient factor expression, and a druginducible Cre recombination system for permanent factor expression.

Tet-On 3G

employs a constitutively expressed Tet transactivator that activates the TRE3G promoter
only when bound to doxycycline.

Factors under control of the TRE3G promoter,

therefore, will be transcribed only upon the administration of doxycycline. ERT2-CreERT2, on the other hand, is a constitutively expressed Cre recombinase that translocates
to the nucleus only when bound to 4-hydroxytamoxifen (4-OHT). Factors are subcloned
into a vector containing a floxed transcriptional stop cassette, pNrl-loxP-STOP-loxP[Factor]. Upon Cre activation by 4-OHT, the stop cassette is permanently removed and
the factor is transcribed continuously under the control of the Nrl promoter.

Cre

activation will also induce recombination of genomic floxed Nrl alleles in the Nrlf/f
mouse, which is important since Nrl knockout likely is required for the induction and
maintenance of cone identity.
All DNA plasmids described here (and summarized in Fig. 4.1) must be
electroporated into the retinas of Nrlf/f P0 mouse pups for efficient uptake into
photoreceptor nuclei.

In vivo electroporation is a well-established method for

transduction of retinal cells, and individual cells have been shown to co-express multiple
electroporated constructs (de Melo and Blackshaw, 2011; Matsuda and Cepko, 2004,
2007, 2008). Certain factors including the Tet transactivator, drug-inducible Cre, and
fluorescent electroporation control will be expressed immediately in rod precursors under
112

the control of the 3.2-kb mouse Nrl promoter. The reprogramming factors, however, will
not be expressed until mice are treated with doxycycline or 4-OHT at a later timepoint.
Doxycycline can be injected intraperitoneally (IP) or incorporated into mouse chow and
water. Expression of the transient factors will commence upon initiation of doxycycline
treatment and cease upon drug termination and clearance. 4-OHT or tamoxifen is usually
injected IP, and several consecutive days of treatment may be required to induce
sufficient recombination of reprogramming factor plasmids and the genomic Nrl alleles
(see Chapter 3.9 for details).
After expression of the reprogramming factors for a period of time (which may
require optimization), the mouse must be sacrificed and examined for evidence of rod-tocone transdifferentiation. One possible readout is in situ hybridization for the S-opsin
gene Opn1sw.

Electroporated regions can be identified in retinal cross-sections by

expression of a fluorescent construct such as pNrl-dsRed. If these regions also appear to
exhibit derepression of Opn1sw, then reprogramming may have been successful. A
caveat is that electroporation transduces only a fraction of cells in the ONL, so Opn1sw
derepression may be sparse. However, the presence of Opn1sw in unusual locations,
such as the inner half of the ONL and the dorsal retina, may represent ectopic expression
induced by electroporated reprogramming factors.

Another potential readout is

fluorescent antibody staining with a marker that labels cone cell bodies, such as cone
arrestin. Positive cone arrestin staining in an electroporated, pNrl-dsRed-positive cell
strongly suggests conversion of a rod into a cone, since the Nrl promoter is active in rods
and Nrl mutant cones but not in endogenous cones (Akimoto et al., 2006).
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Potential pitfalls, controls, and preliminary data
The proposed assay is subject to several potential pitfalls. First, reprogramming factor
expression may be too low to influence cell fate. Second, ‘leaky’ factor expression prior
to drug administration might confound the results: factors that promote cone induction at
an early developmental stage (e.g., P0-P14) may not necessarily effect rod-to-cone
reprogramming in fully differentiated rods. Third, normal retinal development might be
impaired by trauma resulting from P0 in vivo electroporation and/or by constitutive
expression of the Tet transactivator and Cre recombinase. Fourth, the drugs used to
induce factor expression, doxycycline and 4-OHT, might be toxic to photoreceptors
(although we observed no obvious 4-OHT-related toxicity in the reprogramming
experiments described in Chapter 3).
Several of these pitfalls may be circumvented by the inclusion of appropriate
controls, including (1) electroporation of all DNA constructs but treatment with vehicle
instead of drugs, (2) electroporation of the reprogramming factors but not the Tet
transactivator and Cre recombinase, followed by treatment with drugs, and (3)
electroporation of all DNA constructs and treatment with drugs in wild-type mice instead
of Nrlf/f mice. Additionally, preliminary testing of this assay in mouse retinal explants
suggests that the Tet-On and Cre induction systems are tightly regulated with minimal
factor expression in the absence of doxycycline or 4-OHT (Fig. 4.2).

In contrast,

expression is robust following the administration of either doxycycline to induce GFP
(Fig. 4.2A) or 4-OHT to induce DsRed (Fig. 4.2B). This pilot experiment, with druginduced expression of fluorescent proteins, should be replicated in vivo prior to the
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testing of actual reprogramming factors. Candidate factors that may promote rod-to-cone
transdifferentiation are listed in Table 4.1.

Future directions
After a successful reprogramming factor ‘cocktail’ has been identified, the result should
be validated by other methods. For example, the factors could be delivered to the adult
mouse retina in vivo via adeno-associated virus (AAV), which would result in much more
widespread transduction than electroporation. Also, if reprogramming requires only a
small number of factors, it may be feasible to create a transgenic mouse line that
expresses the factors in a drug-inducible manner. The latter strategy may be particularly
useful if the reprogrammed mouse is to be subjected to visual function analyses,
including electroretinography, optokinetic reflex testing, and electrophysiological
recording from retinal cells.

4.4

Materials and methods

DNA constructs
The pCAG-stop-DsRed construct has been described previously (‘pCALNL-DsRed’;
Matsuda and Cepko, 2007). To create pRho(2.2 kb)-GFP, the GFP coding sequence from
pCAG-GFP (Matsuda and Cepko, 2004) was cloned in place of DsRed in the pRho(2.2
kb)-DsRed vector (Matsuda and Cepko, 2004) using the EcoRI and NotI restriction sites.
To create pCrx-ERT2-Cre-ERT2, the Crx promoter (kind gift from Connie Myers) was
cloned in place of the CAG promoter in the pCAG-ERT2-Cre-ERT2 vector (Matsuda and
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Cepko, 2007) using the SmaI and NotI restriction sites. To create pNrl(3.2 kb)-Tet3G,
the Tet3G coding sequence was isolated from pCMV-Tet3G (Clontech) using the BamHI
(blunted) and SacII restriction sites. Tet3G was ligated into the pNrl(3.2 kb)-DsRed
vector (Matsuda and Cepko, 2004) in place of DsRed, which was removed by digestion
with NotI (blunted) and SacII. To create pTRE3G-GFP, GFP was isolated from pCAGGFP by PCR with the addition of 5’ SalI and 3’ BglII restriction sites. These sites were
used to insert GFP upstream of the IRES in the pTRE3G-IRES vector (Clontech).

Electroporation and culture of explanted retinas
Electroporation and explant culture of cd1 mouse retinas were performed as described
previously (Hsiau et al., 2007) with the following exceptions. First, each DNA construct
for electroporation was suspended in PBS at a concentration of 0.5 μg/μl for the
doxycycline induction experiment and 1 μg/μl for the 4-OHT induction experiment.
Second, doxycycline was added to the culture medium of experimental wells the day after
electroporation (P1), at a final concentration of 1 ng/μl (1.5 μl of a 2 mg/ml stock was
added to 3 ml culture medium). The medium and doxycycline were refreshed at P5, and
explants were fixed at P8.

Third, 4-OHT was added to the culture medium of

experimental wells on the day of electroporation (P0), at a final concentration of 100 nM
(3 μl of a 100 μM stock was added to 3 ml culture medium). The medium and 4-OHT
were refreshed daily for two more days (P1 and P2), and explants were fixed at P8.
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Figure 4.1:

Scheme for testing combinations of candidate photoreceptor

reprogramming factors in vivo. All DNA plasmid constructs, including the fluorescent
electroporation control(s), Tet transactivator, 4-hydroxytamoxifen (4-OHT)-inducible Cre
recombinase, and reprogramming factors, must be electroporated into the Nrlf/f mouse
retina at postnatal day 0 (P0). The reprogramming factors will not be transcribed until
the mouse is treated with doxycycline to activate factors transiently or with 4-OHT to
activate factors constitutively. 4-OHT will also trigger recombination of the genomic
floxed Nrl alleles. Successful rod-to-cone reprogramming may be evaluated via in situ
hybridization for Opn1sw.
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Figure 4.2: Protein expression is inducible by doxycycline and 4-OHT in mouse
retinal explants. (A) P0 mouse retinas were electroporated with the Tet transactivator
(Tet3G) driven by the 3.2-kb mouse Nrl promoter and with GFP driven by a modified
tetracycline response element. Retinas were grown in explant culture, and doxycycline
was added to experimental cultures at P1 and P5 to induce GFP expression. By P8, GFP
was strongly expressed in the ONL of the doxycycline-treated retinas but not the controls.
(B) P0 mouse retinas were electroporated with (1) a control GFP construct driven by the
2.2-kb bovine Rho promoter, (2) a DsRed construct under control of the CAG promoter
following Cre-mediated recombination of a transcriptional stop cassette, and (3) a 4OHT-inducible Cre recombinase driven by a promoter extracted from the mouse Crx
locus. The electroporated explants were treated with 100 nM 4-OHT from P0-P2 and
grown in culture until P8.

DsRed was expressed in 4-OHT-treated retinas but not

controls.
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Factor name
NeuroD1
Otx2
Crx
Thrb (TRβ2)
Sall3
Rorb (RORβ)
Rora (RORα)
Tet1
Aicda (AID)

Function
Promotion of photoreceptor cell fate (Morrow et al.,
1999; Yan and Wang, 2004)
Promotion of photoreceptor cell fate; activation of
photoreceptor gene expression (Muranishi et al., 2011;
Nishida et al., 2003)
Direct regulation of most rod and cone genes (Chen et
al., 1997; Corbo et al., 2010; Furukawa et al., 1997)
Activation of Opn1mw expression in cones (Ng et al.,
2001)
Activation of Opn1sw expression in cones (de Melo et
al., 2011)
Direct regulation of Opn1sw (Srinivas et al., 2006)
Direct regulation of Opn1sw, Opn1mw, and Arr3
(Fujieda et al., 2009)
Promotion of DNA demethylation by conversion of 5methylcytosine to 5-hydroxymethylcytosine (Guo et al.,
2011)
Demethylation of 5-hydroxymethylcytosine (Fritz and
Papavasiliou, 2010; Guo et al., 2011)

Expression
Transient
Transient
Transient
Constitutive
Constitutive
Constitutive
Constitutive
Transient
Transient

Table 4.1: Candidate factors for rod-to-cone reprogramming. The column on the
right represents an educated guess, based on the factor’s known function or expression
pattern, about whether the factor should be expressed transiently or constitutively.
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